data_1sx0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1sx0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.459 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 4.1 ttt85 . . . . . 0 N--CA 1.457 -0.114 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -83.75 0.58 46.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.648 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -102.63 145.42 30.5 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.5 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -42.03 119.59 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.157 2.571 . . . . 0.0 112.463 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -43.25 135.15 3.2 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.51 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.59 -18.87 42.15 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.669 2.246 . . . . 0.0 112.568 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.2 p -56.21 -27.62 55.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.771 0.32 . . . . 0.0 111.094 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.55 31.93 28.99 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.614 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -90.44 -46.41 8.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.78 -27.99 2.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.383 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -88.99 145.28 25.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 110.746 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.91 167.75 2.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.539 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.459 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -47.16 -68.92 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.347 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -22.69 18.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.292 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -90.27 6.3 43.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.725 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.19 -71.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.767 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.731 0.3 . . . . 0.0 111.342 -179.457 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.482 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -70.84 -0.34 8.87 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -105.52 145.76 31.45 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.591 0.234 . . . . 0.0 110.685 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -44.82 121.6 3.56 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.947 2.431 . . . . 0.0 112.282 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.6 t -41.25 134.26 1.92 Allowed Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.478 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.17 -17.47 52.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.564 2.176 . . . . 0.0 112.656 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.1 p -56.73 -29.59 62.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.78 0.324 . . . . 0.0 110.951 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.92 31.89 14.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.573 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -90.21 -62.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.39 -27.43 0.49 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -93.63 145.97 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.954 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 166.03 3.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.694 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.482 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -47.14 -70.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.272 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -24.08 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.554 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -99.78 15.41 27.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.853 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.32 -75.16 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.537 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.5 m80 . . . . . 0 C--N 1.331 -0.235 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.136 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.85 -13.22 3.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -96.24 144.99 28.78 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.691 0.282 . . . . 0.0 110.626 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.37 119.01 3.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.677 2.251 . . . . 0.0 112.129 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.1 t -35.35 134.85 0.47 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.747 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 -20.41 50.85 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.606 2.204 . . . . 0.0 112.665 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.8 p -56.35 -29.51 61.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 111.023 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.63 36.37 16.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 p -90.15 -54.1 4.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.64 -26.69 0.84 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.611 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -97.52 162.84 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -72.12 166.55 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.948 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -50.07 -54.64 19.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.079 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -11.11 54.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.576 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -100.09 -21.1 15.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -119.96 -70.35 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.3 m170 . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.716 0.293 . . . . 0.0 111.503 -179.434 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -71.69 0.24 9.25 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -105.66 145.41 30.8 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.727 0.298 . . . . 0.0 110.622 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.23 121.8 3.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.952 2.435 . . . . 0.0 112.338 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -40.86 134.34 1.7 Allowed Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.507 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -60.65 -17.27 48.22 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.543 2.162 . . . . 0.0 112.679 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.7 p -56.9 -27.43 60.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.341 . . . . 0.0 111.054 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.25 29.5 19.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.553 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.5 p -90.2 -58.38 2.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.975 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.79 -28.66 1.29 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.396 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.97 131.88 34.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.802 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -53.7 161.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.022 0.439 . . . . 0.0 111.214 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.09 -67.42 0.29 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.946 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -49.53 -25.34 2.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.095 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.44 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -98.02 8.38 44.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.32 -71.47 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.798 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.2 m170 . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.215 -179.621 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.455 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 34.7 ttt180 . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -89.19 0.44 56.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.392 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -98.8 145.68 30.35 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.619 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -41.19 118.35 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.02 2.48 . . . . 0.0 112.457 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.7 t -39.19 134.41 1.12 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.505 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.04 -20.28 60.02 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.479 2.119 . . . . 0.0 112.485 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -57.27 -29.93 64.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.023 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.77 32.85 12.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.584 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -90.24 -40.11 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 110.926 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.17 -34.71 2.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.494 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 145.69 28.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.657 0.265 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 167.35 2.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.527 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.455 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.19 -70.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.26 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -23.06 9.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.448 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -92.8 10.08 32.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.853 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.37 -74.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.312 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.1 m170 . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.716 0.293 . . . . 0.0 111.708 -179.096 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.462 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 2.5 ttt85 . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -85.95 0.13 54.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.688 0.28 . . . . 0.0 111.492 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.82 146.23 31.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -41.9 119.23 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.737 2.291 . . . . 0.0 112.521 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 t -40.71 135.33 1.58 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.512 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.79 -20.72 36.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.565 2.177 . . . . 0.0 112.514 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.5 p -57.77 -27.66 63.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 111.001 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.02 32.91 30.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.574 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 p -90.35 -31.8 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.59 -27.26 5.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -90.3 143.72 26.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.713 0.292 . . . . 0.0 110.801 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.82 172.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.851 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.462 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -53.78 -68.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.195 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.43 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 9.7 pttp -54.59 -23.14 15.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.207 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.82 7.56 36.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.942 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.07 -71.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.785 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.6 m80 . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.731 0.301 . . . . 0.0 111.32 -179.729 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.483 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 8.6 ttp-105 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -87.16 0.27 55.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.662 0.268 . . . . 0.0 111.55 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.16 146.44 31.95 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.522 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -41.41 118.94 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.776 2.317 . . . . 0.0 112.565 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 t -39.6 135.27 1.22 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.558 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.31 -21.12 27.83 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.656 2.237 . . . . 0.0 112.557 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -57.05 -25.57 58.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.35 31.71 45.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.668 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -90.29 -33.83 15.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.53 -25.62 4.47 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -89.56 147.14 24.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.75 168.0 12.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.676 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.483 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -51.9 -64.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.188 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -51.72 -29.02 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 0.0 111.094 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.0 6.62 41.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.55 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.4 t -150.29 -120.21 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.476 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.3 m170 . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.262 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.467 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 14.5 ttt180 . . . . . 0 CA--C 1.528 0.13 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.58 0.47 54.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.772 0.32 . . . . 0.0 111.637 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.05 145.62 30.73 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.647 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -42.12 119.41 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.054 2.503 . . . . 0.0 112.429 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 t -39.59 134.48 1.26 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.559 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.44 -20.43 56.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.615 2.21 . . . . 0.0 112.545 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.1 p -57.88 -30.59 65.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.998 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.67 34.01 14.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.516 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.2 m -90.2 -44.14 9.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.06 -37.5 1.64 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.408 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -83.88 145.96 28.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.768 0.318 . . . . 0.0 110.737 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 171.47 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.571 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.467 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -50.15 -71.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -52.36 -26.07 11.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 0.0 111.272 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -92.43 10.65 29.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.76 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.33 -72.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.142 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.7 m170 . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.652 0.263 . . . . 0.0 111.468 -179.384 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 31.7 ttt180 . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -87.32 0.64 55.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.531 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -102.66 145.44 30.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.665 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.4 Cg_endo -40.91 119.8 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.131 2.554 . . . . 0.0 112.625 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.6 t -40.55 134.71 1.58 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.505 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.05 -18.38 61.32 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.535 2.156 . . . . 0.0 112.587 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.4 p -57.71 -30.64 65.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.745 0.307 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.79 33.52 11.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.551 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 m -90.03 -33.97 16.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.3 -27.68 4.71 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.438 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.55 162.96 14.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.768 0.318 . . . . 0.0 110.777 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 3.6 mmtm -74.23 179.79 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.513 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -61.79 -65.77 0.64 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.57 -23.72 42.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.961 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -89.82 2.8 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.591 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.22 -70.1 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.659 0.266 . . . . 0.0 110.95 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.7 m170 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.451 179.541 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.449 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 30.7 ttt-85 . . . . . 0 C--O 1.231 0.082 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -85.49 0.64 51.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.583 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.7 145.43 30.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.705 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -40.65 118.96 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.171 2.581 . . . . 0.0 112.48 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.4 t -43.4 134.44 3.42 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.445 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.43 -17.05 58.31 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 112.788 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.3 p -56.74 -30.3 63.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 0.0 111.122 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.42 32.23 9.7 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.665 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.9 p -90.2 -61.46 1.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.375 . . . . 0.0 110.861 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.84 -28.0 0.74 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.549 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mtmm -94.84 141.07 29.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.758 0.313 . . . . 0.0 110.99 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.406 ' CG ' ' HG3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -54.94 164.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.449 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -44.77 -59.82 2.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.825 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.71 -35.03 65.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.55 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.406 ' HG3' ' CG ' ' A' ' 15' ' ' LYS . 69.5 mt-30 -90.34 12.24 18.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.825 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.78 -70.05 0.18 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.369 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.437 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 10.3 m170 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.487 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.488 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.38 -0.26 7.88 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -106.34 145.12 30.35 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.668 0.271 . . . . 0.0 110.579 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -45.29 122.45 4.57 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.808 2.339 . . . . 0.0 112.185 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.6 t -40.27 134.37 1.5 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.417 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.74 -16.79 46.03 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.576 2.184 . . . . 0.0 112.786 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -57.1 -29.2 63.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.963 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.82 31.93 14.11 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.531 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 t -90.31 -50.7 5.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.03 -27.94 1.86 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -90.26 159.94 16.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -76.17 163.63 26.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.488 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.32 -64.91 0.66 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.128 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -24.28 36.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.885 0.374 . . . . 0.0 110.823 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -89.9 1.61 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.521 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.39 -69.95 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.684 0.278 . . . . 0.0 111.017 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.0 m170 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.273 179.381 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.447 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 2.1 ttm180 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -88.31 0.3 56.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.633 0.254 . . . . 0.0 111.612 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -100.93 146.1 31.55 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.578 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.5 Cg_endo -42.33 119.39 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.987 2.458 . . . . 0.0 112.25 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 t -39.23 134.4 1.14 Allowed Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.599 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.1 -20.93 63.57 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.557 2.171 . . . . 0.0 112.473 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.1 p -55.41 -27.9 50.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.034 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.36 31.45 19.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.557 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.4 m -90.21 -41.99 11.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.05 -26.47 3.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.459 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.38 131.85 36.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.785 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -51.39 162.61 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.05 0.452 . . . . 0.0 111.184 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.447 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -44.54 -66.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.945 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -22.44 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.845 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 15' ' ' LYS . 3.8 mm100 -93.99 2.54 56.06 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.3 t -150.05 -71.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.861 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.43 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.4 m170 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 111.254 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.443 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.2 ttt180 . . . . . 0 CA--C 1.528 0.108 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.15 0.24 52.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.692 0.282 . . . . 0.0 111.406 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.18 145.57 30.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.505 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.58 119.52 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.139 2.559 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 t -42.32 136.24 2.38 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.384 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.23 -22.47 26.19 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.604 2.203 . . . . 0.0 112.467 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.4 p -59.31 -34.99 72.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.17 38.6 18.14 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.636 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 t -90.29 -36.73 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.343 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.27 -37.28 1.5 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.447 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.65 160.04 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.707 0.289 . . . . 0.0 110.703 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 179.96 3.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.611 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.443 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.5 OUTLIER -55.61 -64.1 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -60.08 -16.87 35.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.338 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -89.46 -20.11 24.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.629 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 t -123.06 -79.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 m80 . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.736 0.303 . . . . 0.0 111.543 -179.356 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.08 -16.24 4.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.581 0.229 . . . . 0.0 111.46 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -91.87 144.83 29.92 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.671 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -48.09 117.62 2.64 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.722 2.281 . . . . 0.0 112.167 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.8 t -34.09 134.55 0.37 Allowed Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.811 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.62 -16.7 49.93 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.65 2.233 . . . . 0.0 112.808 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.0 p -56.88 -25.04 55.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.712 0.291 . . . . 0.0 111.137 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.94 28.58 31.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.693 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -90.36 -46.28 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.06 -26.83 3.08 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -87.85 144.84 26.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 158.24 17.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.693 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.6 OUTLIER -46.34 -61.15 1.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.259 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -55.34 -22.95 21.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.457 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -98.67 8.98 44.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.797 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.17 -69.15 0.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.597 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.1 m170 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.322 . . . . 0.0 111.185 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -69.66 -0.48 6.96 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -109.01 145.39 31.63 Favored Pre-proline 0 C--N 1.332 -0.182 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -44.3 124.02 4.8 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.851 2.367 . . . . 0.0 112.309 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -41.38 136.23 1.83 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.454 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.17 -18.44 44.29 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.569 2.18 . . . . 0.0 112.571 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.1 p -57.43 -36.33 71.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 110.959 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.2 35.82 6.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.489 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -90.07 -73.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.32 -39.23 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.415 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -79.99 -168.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 110.815 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 173.26 6.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -54.91 -66.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.319 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.17 -27.52 46.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.192 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -95.22 9.42 39.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.542 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.41 -71.25 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.081 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.422 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 11.4 m170 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.455 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.487 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -56.66 -14.15 3.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.31 147.21 32.94 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.825 0.345 . . . . 0.0 110.697 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.66 118.4 3.73 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.473 2.115 . . . . 0.0 112.292 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.7 t -35.25 134.69 0.46 Allowed Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.594 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.38 -17.75 55.12 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.604 2.203 . . . . 0.0 112.799 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.9 p -58.53 -27.92 64.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.06 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.94 33.05 24.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.628 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -90.43 -40.08 12.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 110.837 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.17 -5.13 6.38 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.794 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -112.78 149.14 33.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.889 0.376 . . . . 0.0 110.969 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 160.95 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.763 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.487 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -51.55 -64.32 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.017 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -23.16 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.404 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -99.28 8.84 44.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.658 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.33 -69.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.755 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 m170 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.702 0.287 . . . . 0.0 111.347 -179.581 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.479 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -72.04 0.37 9.63 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.792 0.294 . . . . 0.0 111.792 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -107.54 145.16 30.71 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.619 0.247 . . . . 0.0 110.632 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -44.13 122.96 3.93 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.944 2.429 . . . . 0.0 112.309 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.1 t -41.65 135.64 2.04 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.425 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.95 -23.81 53.65 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.537 2.158 . . . . 0.0 112.465 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.4 p -59.94 -41.04 90.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 110.816 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.07 39.41 5.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.635 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -90.11 -39.89 12.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.934 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.4 -30.59 2.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.396 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.24 140.37 31.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 0.0 110.773 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -58.8 169.56 0.97 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.734 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -48.31 -65.67 0.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.796 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -32.7 33.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.8 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.429 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 10.8 mm-40 -93.72 13.65 21.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.626 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.69 -70.31 0.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.278 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.7 m170 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.485 179.532 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.481 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -70.9 0.15 7.92 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -108.69 145.61 31.99 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 120.652 0.263 . . . . 0.0 110.515 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -44.47 123.42 4.55 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.853 2.369 . . . . 0.0 112.247 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 t -41.37 135.52 1.89 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.481 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.3 -22.24 25.79 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.657 2.238 . . . . 0.0 112.491 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.9 p -58.37 -32.33 68.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.3 36.95 19.4 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.583 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -90.17 -44.61 9.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 0.0 110.943 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.72 -27.37 1.63 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -95.92 152.19 18.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 165.99 22.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.23 -67.47 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.224 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -23.02 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.43 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.18 8.54 44.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.577 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.37 -70.02 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.76 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.4 m170 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.771 0.319 . . . . 0.0 111.282 -179.558 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.465 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -90.36 0.72 57.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.659 0.266 . . . . 0.0 111.693 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -96.52 145.65 29.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.692 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.09 117.68 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.095 2.53 . . . . 0.0 112.53 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 t -40.21 136.15 1.36 Allowed Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.488 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.95 -23.04 32.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.661 2.241 . . . . 0.0 112.64 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.8 p -58.68 -30.82 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.957 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.02 35.08 25.24 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.655 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -90.28 -35.81 15.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.941 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.62 -24.97 3.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.514 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.46 134.61 35.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.783 0.325 . . . . 0.0 111.03 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.405 ' HG2' ' HG3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -61.73 164.62 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.776 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.465 ' HB3' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.61 -60.74 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.522 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.6 pttt -52.12 -32.03 33.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.476 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 2.4 mm-40 -89.86 4.95 48.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.46 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.0 t -150.2 -120.57 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.269 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 m170 . . . . . 0 C--O 1.231 0.105 0 O-C-N 122.188 -0.32 . . . . 0.0 111.286 -179.813 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.494 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.425 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -65.96 -5.59 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.32 145.46 30.48 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.68 0.276 . . . . 0.0 110.643 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.75 120.96 4.43 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.823 2.349 . . . . 0.0 112.229 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 t -38.24 134.11 0.92 Allowed Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.591 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.22 -20.69 63.2 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.596 2.197 . . . . 0.0 112.695 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.7 p -58.59 -32.44 68.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.44 35.58 8.57 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.544 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.7 p -90.1 -39.72 12.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.96 -27.62 3.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.47 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.45 144.03 26.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.879 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -60.26 163.22 5.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.494 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -46.34 -64.68 0.7 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.307 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.44 -25.99 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.268 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -94.37 5.87 50.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.614 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.16 -70.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.741 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 11.1 m170 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 111.241 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.789 0.328 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.469 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.6 p -81.03 146.09 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.227 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.97 96.22 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.479 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.459 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 4.1 ttt85 -47.48 -28.19 2.08 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -83.75 0.58 46.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.648 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -102.63 145.42 30.5 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.5 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -42.03 119.59 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.157 2.571 . . . . 0.0 112.463 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -43.25 135.15 3.2 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.51 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.59 -18.87 42.15 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.669 2.246 . . . . 0.0 112.568 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.2 p -56.21 -27.62 55.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.771 0.32 . . . . 0.0 111.094 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.55 31.93 28.99 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.614 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -90.44 -46.41 8.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.78 -27.99 2.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.383 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -88.99 145.28 25.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 110.746 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.91 167.75 2.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.539 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.469 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.4 OUTLIER -47.16 -68.92 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.347 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -22.69 18.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.292 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -90.27 6.3 43.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.725 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.19 -71.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.767 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -93.66 -48.77 6.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.731 0.3 . . . . 0.0 111.342 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.77 -28.78 2.78 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.96 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.796 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.459 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.5 p -100.87 153.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.203 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.452 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -72.0 81.0 0.57 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.117 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.482 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.97 -29.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -70.84 -0.34 8.87 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.8 t70 -105.52 145.76 31.45 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.591 0.234 . . . . 0.0 110.685 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -44.82 121.6 3.56 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.947 2.431 . . . . 0.0 112.282 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.6 t -41.25 134.26 1.92 Allowed Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.478 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.17 -17.47 52.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.564 2.176 . . . . 0.0 112.656 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.1 p -56.73 -29.59 62.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.78 0.324 . . . . 0.0 110.951 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.92 31.89 14.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.573 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -90.21 -62.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.39 -27.43 0.49 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -93.63 145.97 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.954 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.5 166.03 3.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.694 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.482 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -47.14 -70.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.272 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -24.08 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.554 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -99.78 15.41 27.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.853 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.32 -75.16 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.537 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -125.17 1.46 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . -56.19 -25.35 47.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.679 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.5 mttt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.85 0.357 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.4 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 13.2 p -101.53 144.56 12.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.17 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 5' ' ' ASN . . . -70.81 80.29 0.45 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.057 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -32.02 -35.46 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 3' ' ' GLY . 15.3 t-20 -57.85 -13.22 3.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -96.24 144.99 28.78 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.691 0.282 . . . . 0.0 110.626 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.37 119.01 3.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.677 2.251 . . . . 0.0 112.129 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.1 t -35.35 134.85 0.47 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.747 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 -20.41 50.85 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.606 2.204 . . . . 0.0 112.665 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.8 p -56.35 -29.51 61.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 111.023 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.63 36.37 16.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 p -90.15 -54.1 4.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.64 -26.69 0.84 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.611 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -97.52 162.84 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -72.12 166.55 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.948 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -50.07 -54.64 19.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.079 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -11.11 54.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.576 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -100.09 -21.1 15.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -119.96 -70.35 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -87.79 -74.85 0.43 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.716 0.293 . . . . 0.0 111.503 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.62 -29.63 1.95 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.046 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.888 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.846 0.355 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.3 p -88.67 155.76 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.451 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -73.95 80.03 0.84 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.066 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.508 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.38 -30.14 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -71.69 0.24 9.25 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.3 t70 -105.66 145.41 30.8 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.727 0.298 . . . . 0.0 110.622 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.23 121.8 3.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.952 2.435 . . . . 0.0 112.338 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -40.86 134.34 1.7 Allowed Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.507 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -60.65 -17.27 48.22 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.543 2.162 . . . . 0.0 112.679 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.7 p -56.9 -27.43 60.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.341 . . . . 0.0 111.054 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.25 29.5 19.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.553 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.5 p -90.2 -58.38 2.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.975 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.79 -28.66 1.29 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.396 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.97 131.88 34.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.802 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.44 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -53.7 161.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.022 0.439 . . . . 0.0 111.214 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.508 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.09 -67.42 0.29 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.946 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -49.53 -25.34 2.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.095 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.44 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -98.02 8.38 44.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.32 -71.47 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.798 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -97.39 -53.3 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.215 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.59 -30.29 2.13 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.035 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.946 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.859 0.362 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.3 p -121.7 144.89 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.17 98.76 0.15 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.27 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.455 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 34.7 ttt180 -49.3 -27.81 4.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -89.19 0.44 56.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.392 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -98.8 145.68 30.35 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.619 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -41.19 118.35 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.02 2.48 . . . . 0.0 112.457 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.7 t -39.19 134.41 1.12 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.505 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.04 -20.28 60.02 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.479 2.119 . . . . 0.0 112.485 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -57.27 -29.93 64.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.023 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.77 32.85 12.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.584 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -90.24 -40.11 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 110.926 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.17 -34.71 2.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.494 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 145.69 28.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.657 0.265 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.36 167.35 2.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.527 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.467 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -48.19 -70.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.26 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -23.06 9.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.448 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -92.8 10.08 32.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.853 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.37 -74.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.312 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -99.54 -27.18 13.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.716 0.293 . . . . 0.0 111.708 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.25 -24.02 9.28 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.994 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.126 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.828 0.346 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.4 p -124.95 147.49 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.251 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.94 98.67 0.17 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.132 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.462 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 2.5 ttt85 -48.17 -28.51 3.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -85.95 0.13 54.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.688 0.28 . . . . 0.0 111.492 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.82 146.23 31.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -41.9 119.23 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.737 2.291 . . . . 0.0 112.521 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 t -40.71 135.33 1.58 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.512 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.79 -20.72 36.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.565 2.177 . . . . 0.0 112.514 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.5 p -57.77 -27.66 63.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 111.001 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.02 32.91 30.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.574 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 p -90.35 -31.8 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.59 -27.26 5.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -90.3 143.72 26.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.713 0.292 . . . . 0.0 110.801 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.82 172.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.851 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.462 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -53.78 -68.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.195 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.43 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 9.7 pttp -54.59 -23.14 15.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.207 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.82 7.56 36.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.942 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.07 -71.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.785 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -105.76 -44.84 4.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.731 0.301 . . . . 0.0 111.32 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.98 -25.25 16.4 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.669 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' N ' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.054 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.88 0.371 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.46 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.0 p -87.31 150.1 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.52 95.6 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.194 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.483 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 8.6 ttp-105 -48.05 -27.36 2.24 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -87.16 0.27 55.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.662 0.268 . . . . 0.0 111.55 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.16 146.44 31.95 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.522 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -41.41 118.94 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.776 2.317 . . . . 0.0 112.565 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 t -39.6 135.27 1.22 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.558 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.31 -21.12 27.83 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.656 2.237 . . . . 0.0 112.557 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -57.05 -25.57 58.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.35 31.71 45.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.668 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -90.29 -33.83 15.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.53 -25.62 4.47 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -89.56 147.14 24.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.75 168.0 12.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.676 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.483 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -51.9 -64.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.188 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -51.72 -29.02 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 0.0 111.094 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.0 6.62 41.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.55 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.4 t -150.29 -120.21 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.476 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.3 m170 -62.93 -18.76 63.52 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.05 -27.2 6.65 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.803 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.811 0.339 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.476 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 15.0 p -121.39 147.41 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.56 97.35 0.14 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.334 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.467 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 14.5 ttt180 -47.67 -28.65 2.51 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.58 0.47 54.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.772 0.32 . . . . 0.0 111.637 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.05 145.62 30.73 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.647 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -42.12 119.41 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.054 2.503 . . . . 0.0 112.429 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 t -39.59 134.48 1.26 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.559 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.44 -20.43 56.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.615 2.21 . . . . 0.0 112.545 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.1 p -57.88 -30.59 65.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.998 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.67 34.01 14.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.516 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.2 m -90.2 -44.14 9.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.06 -37.5 1.64 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.408 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -83.88 145.96 28.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.768 0.318 . . . . 0.0 110.737 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.69 171.47 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.571 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.476 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -50.15 -71.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -52.36 -26.07 11.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 0.0 111.272 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -92.43 10.65 29.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.76 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.33 -72.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.142 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -116.45 -34.98 4.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.652 0.263 . . . . 0.0 111.468 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.11 -29.61 1.61 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.986 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 mtm105 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.889 179.817 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.752 0.311 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.49 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.6 p -84.34 148.12 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.72 96.3 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.206 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 31.7 ttt180 -47.52 -27.7 1.9 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -87.32 0.64 55.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.531 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -102.66 145.44 30.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.665 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.4 Cg_endo -40.91 119.8 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.131 2.554 . . . . 0.0 112.625 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.6 t -40.55 134.71 1.58 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.505 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.05 -18.38 61.32 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.535 2.156 . . . . 0.0 112.587 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.4 p -57.71 -30.64 65.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.745 0.307 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.79 33.52 11.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.551 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 m -90.03 -33.97 16.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.3 -27.68 4.71 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.438 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.55 162.96 14.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.768 0.318 . . . . 0.0 110.777 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 3.6 mmtm -74.23 179.79 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.513 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -61.79 -65.77 0.64 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.57 -23.72 42.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.961 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -89.82 2.8 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.591 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.22 -70.1 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.659 0.266 . . . . 0.0 110.95 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 22' ' ' ARG . 8.7 m170 -94.08 -86.17 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.451 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.432 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 50.56 -84.05 0.01 OUTLIER Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.081 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 20' ' ' HIS . 17.4 ptm180 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.939 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.1 pttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.77 0.319 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.5 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.5 p -106.96 142.92 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.7 97.59 0.12 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.329 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.449 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 30.7 ttt-85 -47.55 -28.59 2.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -85.49 0.64 51.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.583 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.7 145.43 30.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.705 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -40.65 118.96 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.171 2.581 . . . . 0.0 112.48 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.4 t -43.4 134.44 3.42 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.445 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.43 -17.05 58.31 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 112.788 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.3 p -56.74 -30.3 63.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 0.0 111.122 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.42 32.23 9.7 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.665 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.9 p -90.2 -61.46 1.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.375 . . . . 0.0 110.861 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.84 -28.0 0.74 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.549 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mtmm -94.84 141.07 29.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.758 0.313 . . . . 0.0 110.99 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.406 ' CG ' ' HG3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -54.94 164.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.5 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -44.77 -59.82 2.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.825 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.71 -35.03 65.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.55 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.406 ' HG3' ' CG ' ' A' ' 15' ' ' LYS . 69.5 mt-30 -90.34 12.24 18.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.825 -179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.78 -70.05 0.18 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.369 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' ARG . 10.3 m170 -99.65 -85.2 0.4 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.487 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.423 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 50.74 -84.13 0.01 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.879 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.975 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.96 0.41 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.457 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 12.8 p -106.17 158.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.15 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -71.72 79.49 0.58 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.382 -0.914 . . . . 0.0 111.335 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.488 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.38 -30.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.38 -0.26 7.88 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.5 t70 -106.34 145.12 30.35 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.668 0.271 . . . . 0.0 110.579 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -45.29 122.45 4.57 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.808 2.339 . . . . 0.0 112.185 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.6 t -40.27 134.37 1.5 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.417 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.74 -16.79 46.03 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.576 2.184 . . . . 0.0 112.786 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -57.1 -29.2 63.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.963 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.82 31.93 14.11 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.531 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 t -90.31 -50.7 5.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.03 -27.94 1.86 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -90.26 159.94 16.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -76.17 163.63 26.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.488 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.32 -64.91 0.66 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.128 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -24.28 36.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.885 0.374 . . . . 0.0 110.823 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -89.9 1.61 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.521 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.39 -69.95 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.684 0.278 . . . . 0.0 111.017 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.51 ' O ' ' N ' ' A' ' 22' ' ' ARG . 7.0 m170 -91.08 -83.99 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.273 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 49.65 -84.03 0.01 OUTLIER Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.09 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 20' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.894 0.378 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.4 p -125.43 154.17 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.145 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -62.62 94.97 0.11 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.233 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.447 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 2.1 ttm180 -47.72 -28.17 2.33 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -88.31 0.3 56.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.633 0.254 . . . . 0.0 111.612 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -100.93 146.1 31.55 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.578 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.5 Cg_endo -42.33 119.39 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.987 2.458 . . . . 0.0 112.25 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 t -39.23 134.4 1.14 Allowed Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.599 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.1 -20.93 63.57 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.557 2.171 . . . . 0.0 112.473 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.1 p -55.41 -27.9 50.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.034 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.36 31.45 19.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.557 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.4 m -90.21 -41.99 11.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.05 -26.47 3.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.459 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.38 131.85 36.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.785 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -51.39 162.61 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.05 0.452 . . . . 0.0 111.184 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.489 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -44.54 -66.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.945 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -22.44 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.845 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.406 ' HB2' ' HD2' ' A' ' 15' ' ' LYS . 3.8 mm100 -93.99 2.54 56.06 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.3 t -150.05 -71.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.861 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.43 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.4 m170 -88.2 -55.56 3.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 111.254 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.32 -34.19 3.3 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.131 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.791 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.7 mptt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.861 0.362 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.47 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.3 p -88.73 139.43 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.8 99.65 0.14 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.303 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.443 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 9.2 ttt180 -48.08 -28.2 2.74 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.15 0.24 52.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.692 0.282 . . . . 0.0 111.406 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.18 145.57 30.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.505 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -41.58 119.52 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.139 2.559 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 t -42.32 136.24 2.38 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.384 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.23 -22.47 26.19 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.604 2.203 . . . . 0.0 112.467 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.4 p -59.31 -34.99 72.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.17 38.6 18.14 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.636 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 t -90.29 -36.73 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.343 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.27 -37.28 1.5 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.447 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.65 160.04 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.707 0.289 . . . . 0.0 110.703 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 179.96 3.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.611 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.47 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -55.61 -64.1 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.417 ' HA ' ' N ' ' A' ' 22' ' ' ARG . 3.0 pttp -60.08 -16.87 35.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.338 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -89.46 -20.11 24.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.629 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 t -123.06 -79.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -86.55 -59.22 2.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.736 0.303 . . . . 0.0 111.543 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -46.53 -32.09 5.36 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.87 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.417 ' N ' ' HA ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.112 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.9 145.16 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.277 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 5' ' ' ASN . . . -69.87 79.26 0.37 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.097 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -33.17 -34.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 3' ' ' GLY . 0.4 OUTLIER -56.08 -16.24 4.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.581 0.229 . . . . 0.0 111.46 179.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -91.87 144.83 29.92 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.671 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -48.09 117.62 2.64 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.722 2.281 . . . . 0.0 112.167 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.8 t -34.09 134.55 0.37 Allowed Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.811 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.62 -16.7 49.93 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.65 2.233 . . . . 0.0 112.808 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.0 p -56.88 -25.04 55.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.712 0.291 . . . . 0.0 111.137 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.94 28.58 31.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.693 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -90.36 -46.28 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.06 -26.83 3.08 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -87.85 144.84 26.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 158.24 17.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.693 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.6 OUTLIER -46.34 -61.15 1.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.259 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -55.34 -22.95 21.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.457 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -98.67 8.98 44.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.797 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.17 -69.15 0.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.597 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.1 m170 -93.05 -58.14 2.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.322 . . . . 0.0 111.185 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.82 -26.31 8.03 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.78 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.908 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.5 mttt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.846 0.355 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.45 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 12.7 p -121.23 157.82 24.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.239 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -80.76 85.36 1.37 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.397 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -37.68 -29.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -69.66 -0.48 6.96 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.6 t70 -109.01 145.39 31.63 Favored Pre-proline 0 C--N 1.332 -0.182 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -44.3 124.02 4.8 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.851 2.367 . . . . 0.0 112.309 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -41.38 136.23 1.83 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.454 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.17 -18.44 44.29 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.569 2.18 . . . . 0.0 112.571 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.1 p -57.43 -36.33 71.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 110.959 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.2 35.82 6.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.489 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -90.07 -73.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.32 -39.23 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.415 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -79.99 -168.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 110.815 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.64 173.26 6.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -54.91 -66.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.319 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.17 -27.52 46.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.192 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -95.22 9.42 39.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.542 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.41 -71.25 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.081 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.487 ' O ' ' N ' ' A' ' 22' ' ' ARG . 11.4 m170 -95.93 -84.05 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.455 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.432 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 50.52 -84.32 0.01 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.002 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 20' ' ' HIS . 77.5 mtt180 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.889 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.829 0.347 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p -73.13 145.73 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.202 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 5' ' ' ASN . . . -69.54 81.41 0.3 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.316 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.487 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -32.53 -35.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 3' ' ' GLY . 62.7 t30 -56.66 -14.15 3.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.31 147.21 32.94 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.825 0.345 . . . . 0.0 110.697 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.66 118.4 3.73 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.473 2.115 . . . . 0.0 112.292 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 33.7 t -35.25 134.69 0.46 Allowed Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.594 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.38 -17.75 55.12 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.604 2.203 . . . . 0.0 112.799 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.9 p -58.53 -27.92 64.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.06 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.94 33.05 24.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.628 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -90.43 -40.08 12.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 110.837 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.17 -5.13 6.38 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.794 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -112.78 149.14 33.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.889 0.376 . . . . 0.0 110.969 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 160.95 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.763 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.487 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -51.55 -64.32 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.017 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -23.16 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.404 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -99.28 8.84 44.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.658 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.33 -69.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.755 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -99.07 -54.48 2.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.702 0.287 . . . . 0.0 111.347 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.29 -29.19 1.61 Allowed Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.986 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.889 179.878 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.455 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.4 p -113.55 157.92 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.231 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.431 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -78.24 83.57 1.19 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.258 178.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.479 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -37.23 -29.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -72.04 0.37 9.63 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.792 0.294 . . . . 0.0 111.792 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 3' ' ' GLY . 6.2 t70 -107.54 145.16 30.71 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.619 0.247 . . . . 0.0 110.632 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -44.13 122.96 3.93 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.944 2.429 . . . . 0.0 112.309 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.1 t -41.65 135.64 2.04 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.425 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.95 -23.81 53.65 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.537 2.158 . . . . 0.0 112.465 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.4 p -59.94 -41.04 90.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 110.816 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.07 39.41 5.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.635 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -90.11 -39.89 12.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.934 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.4 -30.59 2.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.396 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.24 140.37 31.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 0.0 110.773 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -58.8 169.56 0.97 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.734 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.479 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -48.31 -65.67 0.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.796 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -32.7 33.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.8 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.429 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 10.8 mm-40 -93.72 13.65 21.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.626 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.69 -70.31 0.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.278 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.487 ' O ' ' N ' ' A' ' 22' ' ' ARG . 10.7 m170 -100.24 -86.86 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.485 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.432 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 51.58 -84.25 0.01 OUTLIER Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.826 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 20' ' ' HIS . 6.4 mtt-85 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.821 0.343 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.453 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 13.3 p -106.14 158.42 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.23 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 6' ' ' ASP . . . -76.73 82.33 1.08 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.273 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.481 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -37.42 -29.46 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -70.9 0.15 7.92 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 3' ' ' GLY . 7.2 t70 -108.69 145.61 31.99 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 120.652 0.263 . . . . 0.0 110.515 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -44.47 123.42 4.55 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.853 2.369 . . . . 0.0 112.247 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 t -41.37 135.52 1.89 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.481 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.3 -22.24 25.79 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.657 2.238 . . . . 0.0 112.491 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.9 p -58.37 -32.33 68.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.3 36.95 19.4 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.583 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -90.17 -44.61 9.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 0.0 110.943 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.72 -27.37 1.63 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -95.92 152.19 18.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.8 165.99 22.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.481 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.23 -67.47 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.224 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -23.02 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.43 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.18 8.54 44.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.577 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.37 -70.02 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.76 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -98.55 -52.99 3.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.771 0.319 . . . . 0.0 111.282 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.6 -28.2 2.37 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.016 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.903 179.954 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.828 0.347 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.488 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.5 p -116.33 145.87 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.144 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.03 96.03 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.237 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.465 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -47.74 -28.14 2.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -90.36 0.72 57.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.659 0.266 . . . . 0.0 111.693 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -96.52 145.65 29.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.692 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -41.09 117.68 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.095 2.53 . . . . 0.0 112.53 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 t -40.21 136.15 1.36 Allowed Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.488 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.95 -23.04 32.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.661 2.241 . . . . 0.0 112.64 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.8 p -58.68 -30.82 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.957 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.02 35.08 25.24 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.655 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -90.28 -35.81 15.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.941 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.62 -24.97 3.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.514 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.46 134.61 35.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.783 0.325 . . . . 0.0 111.03 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.405 ' HG2' ' HG3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -61.73 164.62 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.776 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.488 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -45.61 -60.74 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.522 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.6 pttt -52.12 -32.03 33.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.476 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 2.4 mm-40 -89.86 4.95 48.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.46 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.0 t -150.2 -120.57 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.269 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -51.98 -42.64 63.1 Favored 'General case' 0 C--O 1.231 0.105 0 O-C-N 122.188 -0.32 . . . . 0.0 111.286 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.85 -27.91 59.89 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.598 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.846 0.355 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 13.3 p -125.0 150.78 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.191 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.53 80.01 0.43 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.306 -0.949 . . . . 0.0 111.045 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.494 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -35.57 -31.01 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -65.96 -5.59 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.32 145.46 30.48 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.68 0.276 . . . . 0.0 110.643 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.75 120.96 4.43 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.823 2.349 . . . . 0.0 112.229 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 t -38.24 134.11 0.92 Allowed Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.591 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.22 -20.69 63.2 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.596 2.197 . . . . 0.0 112.695 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.7 p -58.59 -32.44 68.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.44 35.58 8.57 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.544 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.7 p -90.1 -39.72 12.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.96 -27.62 3.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.47 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.45 144.03 26.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.879 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -60.26 163.22 5.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.494 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -46.34 -64.68 0.7 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.307 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.44 -25.99 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.268 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -94.37 5.87 50.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.614 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.16 -70.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.741 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 11.1 m170 -98.58 -59.87 1.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 111.241 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.95 -27.49 5.02 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.782 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.98 179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 4.1 ttt85 . . . . . 0 N--CA 1.457 -0.114 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -83.75 0.58 46.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.648 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -102.63 145.42 30.5 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.5 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.7 Cg_endo -42.03 119.59 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.157 2.571 . . . . 0.0 112.463 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -43.25 135.15 3.2 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.51 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.59 -18.87 42.15 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.669 2.246 . . . . 0.0 112.568 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.456 ' HB3' ' CE1' ' A' ' 20' ' ' HIS . 30.2 p -56.21 -27.62 55.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.771 0.32 . . . . 0.0 111.094 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.55 31.93 28.99 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.614 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -90.44 -46.41 8.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.78 -27.99 2.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.383 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -88.99 145.28 25.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 110.746 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -59.91 167.75 2.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.539 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.475 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -47.16 -68.92 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.347 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -22.69 18.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.292 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -90.27 6.3 43.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.725 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.19 -71.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.767 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' A' ' 10' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.731 0.3 . . . . 0.0 111.342 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.485 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.84 -0.34 8.87 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -105.52 145.76 31.45 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.591 0.234 . . . . 0.0 110.685 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 Cg_endo -44.82 121.6 3.56 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.947 2.431 . . . . 0.0 112.282 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.6 t -41.25 134.26 1.92 Allowed Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.478 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.17 -17.47 52.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.564 2.176 . . . . 0.0 112.656 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.1 p -56.73 -29.59 62.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.78 0.324 . . . . 0.0 110.951 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.92 31.89 14.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.573 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -90.21 -62.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.39 -27.43 0.49 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -93.63 145.97 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.954 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.5 166.03 3.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.694 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.485 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -47.14 -70.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.272 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -24.08 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.554 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -99.78 15.41 27.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.853 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.32 -75.16 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.537 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.5 m80 . . . . . 0 C--N 1.331 -0.235 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.136 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.463 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.85 -13.22 3.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -96.24 144.99 28.78 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.691 0.282 . . . . 0.0 110.626 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.37 119.01 3.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.677 2.251 . . . . 0.0 112.129 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.1 t -35.35 134.85 0.47 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.747 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 -20.41 50.85 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.606 2.204 . . . . 0.0 112.665 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.8 p -56.35 -29.51 61.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 111.023 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.63 36.37 16.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 p -90.15 -54.1 4.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.64 -26.69 0.84 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.611 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -97.52 162.84 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -72.12 166.55 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.948 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -50.07 -54.64 19.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.079 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -11.11 54.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.576 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -100.09 -21.1 15.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -119.96 -70.35 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.3 m170 . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.716 0.293 . . . . 0.0 111.503 -179.434 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.514 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -71.69 0.24 9.25 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -105.66 145.41 30.8 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.727 0.298 . . . . 0.0 110.622 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 Cg_endo -44.23 121.8 3.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.952 2.435 . . . . 0.0 112.338 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -40.86 134.34 1.7 Allowed Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.507 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -60.65 -17.27 48.22 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.543 2.162 . . . . 0.0 112.679 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.7 p -56.9 -27.43 60.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.341 . . . . 0.0 111.054 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.25 29.5 19.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.553 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.5 p -90.2 -58.38 2.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.975 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.79 -28.66 1.29 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.396 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.97 131.88 34.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.802 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -53.7 161.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.022 0.439 . . . . 0.0 111.214 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.514 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.09 -67.42 0.29 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.946 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -49.53 -25.34 2.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.095 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.49 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -98.02 8.38 44.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.32 -71.47 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.798 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.2 m170 . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.215 -179.621 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.474 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 34.7 ttt180 . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -89.19 0.44 56.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.392 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -98.8 145.68 30.35 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.619 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.1 Cg_endo -41.19 118.35 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.02 2.48 . . . . 0.0 112.457 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.7 t -39.19 134.41 1.12 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.505 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.04 -20.28 60.02 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.479 2.119 . . . . 0.0 112.485 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -57.27 -29.93 64.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.023 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.77 32.85 12.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.584 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -90.24 -40.11 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 110.926 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.17 -34.71 2.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.494 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 145.69 28.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.657 0.265 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.36 167.35 2.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.527 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.474 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.19 -70.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.26 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -23.06 9.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.448 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -92.8 10.08 32.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.853 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.37 -74.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.312 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.1 m170 . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.716 0.293 . . . . 0.0 111.708 -179.096 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 2.5 ttt85 . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -85.95 0.13 54.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.688 0.28 . . . . 0.0 111.492 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.82 146.23 31.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 97.4 Cg_exo -41.9 119.23 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.737 2.291 . . . . 0.0 112.521 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 t -40.71 135.33 1.58 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.512 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.79 -20.72 36.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.565 2.177 . . . . 0.0 112.514 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.5 p -57.77 -27.66 63.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 111.001 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.02 32.91 30.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.574 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 p -90.35 -31.8 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.59 -27.26 5.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -90.3 143.72 26.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.713 0.292 . . . . 0.0 110.801 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -58.82 172.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.851 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.478 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -53.78 -68.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.195 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 9.7 pttp -54.59 -23.14 15.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.207 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.82 7.56 36.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.942 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.07 -71.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.785 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.6 m80 . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.731 0.301 . . . . 0.0 111.32 -179.729 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 8.6 ttp-105 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -87.16 0.27 55.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.662 0.268 . . . . 0.0 111.55 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.16 146.44 31.95 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.522 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 85.6 Cg_exo -41.41 118.94 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.776 2.317 . . . . 0.0 112.565 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 t -39.6 135.27 1.22 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.558 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.31 -21.12 27.83 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.656 2.237 . . . . 0.0 112.557 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -57.05 -25.57 58.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.35 31.71 45.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.668 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -90.29 -33.83 15.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.53 -25.62 4.47 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -89.56 147.14 24.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -67.75 168.0 12.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.676 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -51.9 -64.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.188 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -51.72 -29.02 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 0.0 111.094 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.0 6.62 41.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.55 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.4 t -150.29 -120.21 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.476 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.3 m170 . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.262 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.483 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 14.5 ttt180 . . . . . 0 CA--C 1.528 0.13 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.58 0.47 54.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.772 0.32 . . . . 0.0 111.637 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.05 145.62 30.73 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.647 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.7 Cg_endo -42.12 119.41 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.054 2.503 . . . . 0.0 112.429 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 t -39.59 134.48 1.26 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.559 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.44 -20.43 56.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.615 2.21 . . . . 0.0 112.545 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.1 p -57.88 -30.59 65.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.998 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.67 34.01 14.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.516 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.2 m -90.2 -44.14 9.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.06 -37.5 1.64 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.408 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -83.88 145.96 28.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.768 0.318 . . . . 0.0 110.737 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.69 171.47 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.571 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.483 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -50.15 -71.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -52.36 -26.07 11.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 0.0 111.272 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -92.43 10.65 29.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.76 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.33 -72.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.142 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.7 m170 . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.652 0.263 . . . . 0.0 111.468 -179.384 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.528 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 31.7 ttt180 . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -87.32 0.64 55.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.531 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -102.66 145.44 30.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.665 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.4 Cg_endo -40.91 119.8 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.131 2.554 . . . . 0.0 112.625 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.6 t -40.55 134.71 1.58 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.505 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.05 -18.38 61.32 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.535 2.156 . . . . 0.0 112.587 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.4 p -57.71 -30.64 65.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.745 0.307 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.79 33.52 11.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.551 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 m -90.03 -33.97 16.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.3 -27.68 4.71 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.438 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -91.55 162.96 14.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.768 0.318 . . . . 0.0 110.777 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 3.6 mmtm -74.23 179.79 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -61.79 -65.77 0.64 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.57 -23.72 42.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.961 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 1.3 tm0? -89.82 2.8 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.591 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.22 -70.1 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.659 0.266 . . . . 0.0 110.95 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.7 m170 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.451 179.541 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.468 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 30.7 ttt-85 . . . . . 0 C--O 1.231 0.082 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -85.49 0.64 51.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.583 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.7 145.43 30.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.705 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.0 Cg_exo -40.65 118.96 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.171 2.581 . . . . 0.0 112.48 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.463 ' HG ' ' HG ' ' A' ' 10' ' ' CYS . 23.4 t -43.4 134.44 3.42 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.445 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.43 -17.05 58.31 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 112.788 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.463 ' HG ' ' HG ' ' A' ' 8' ' ' CYS . 20.3 p -56.74 -30.3 63.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 0.0 111.122 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.42 32.23 9.7 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.665 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.9 p -90.2 -61.46 1.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.375 . . . . 0.0 110.861 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.84 -28.0 0.74 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.549 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mtmm -94.84 141.07 29.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.758 0.313 . . . . 0.0 110.99 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -54.94 164.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.468 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -44.77 -59.82 2.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.825 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HB3' ' NH1' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -55.71 -35.03 65.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.55 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -90.34 12.24 18.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.825 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.78 -70.05 0.18 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.369 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.46 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 10.3 m170 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.487 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.493 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.38 -0.26 7.88 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -106.34 145.12 30.35 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.668 0.271 . . . . 0.0 110.579 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.7 Cg_endo -45.29 122.45 4.57 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.808 2.339 . . . . 0.0 112.185 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.6 t -40.27 134.37 1.5 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.417 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.74 -16.79 46.03 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.576 2.184 . . . . 0.0 112.786 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -57.1 -29.2 63.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.963 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.82 31.93 14.11 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.531 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 t -90.31 -50.7 5.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.03 -27.94 1.86 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -90.26 159.94 16.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -76.17 163.63 26.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.493 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.32 -64.91 0.66 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.128 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -24.28 36.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.885 0.374 . . . . 0.0 110.823 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.9 1.61 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.521 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.39 -69.95 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.684 0.278 . . . . 0.0 111.017 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.407 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.0 m170 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.273 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 2.1 ttm180 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -88.31 0.3 56.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.633 0.254 . . . . 0.0 111.612 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -100.93 146.1 31.55 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.578 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.5 Cg_endo -42.33 119.39 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.987 2.458 . . . . 0.0 112.25 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 t -39.23 134.4 1.14 Allowed Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.599 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.1 -20.93 63.57 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.557 2.171 . . . . 0.0 112.473 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.1 p -55.41 -27.9 50.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.034 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.36 31.45 19.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.557 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.4 m -90.21 -41.99 11.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.05 -26.47 3.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.459 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -91.38 131.85 36.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.785 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -51.39 162.61 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.05 0.452 . . . . 0.0 111.184 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -44.54 -66.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.945 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -22.44 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.845 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.436 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 3.8 mm100 -93.99 2.54 56.06 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.3 t -150.05 -71.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.861 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.4 m170 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 111.254 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.46 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 9.2 ttt180 . . . . . 0 CA--C 1.528 0.108 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.15 0.24 52.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.692 0.282 . . . . 0.0 111.406 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.18 145.57 30.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.505 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.0 Cg_endo -41.58 119.52 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.139 2.559 . . . . 0.0 112.473 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 t -42.32 136.24 2.38 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.384 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.23 -22.47 26.19 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.604 2.203 . . . . 0.0 112.467 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.4 p -59.31 -34.99 72.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.17 38.6 18.14 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.636 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 t -90.29 -36.73 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.343 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.27 -37.28 1.5 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.447 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.65 160.04 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.707 0.289 . . . . 0.0 110.703 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -72.15 179.96 3.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.611 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.46 ' HB3' ' HA ' ' A' ' 4' ' ' ARG . 0.5 OUTLIER -55.61 -64.1 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -60.08 -16.87 35.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.338 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -89.46 -20.11 24.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.629 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 t -123.06 -79.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 m80 . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.736 0.303 . . . . 0.0 111.543 -179.356 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.08 -16.24 4.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.581 0.229 . . . . 0.0 111.46 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -91.87 144.83 29.92 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.671 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -48.09 117.62 2.64 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.722 2.281 . . . . 0.0 112.167 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.8 t -34.09 134.55 0.37 Allowed Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.811 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.62 -16.7 49.93 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.65 2.233 . . . . 0.0 112.808 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.0 p -56.88 -25.04 55.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.712 0.291 . . . . 0.0 111.137 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.94 28.58 31.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.693 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -90.36 -46.28 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.06 -26.83 3.08 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -87.85 144.84 26.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 158.24 17.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.693 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.6 OUTLIER -46.34 -61.15 1.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.259 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -55.34 -22.95 21.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.457 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -98.67 8.98 44.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.797 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.17 -69.15 0.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.597 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.462 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.1 m170 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.322 . . . . 0.0 111.185 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.505 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -69.66 -0.48 6.96 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -109.01 145.39 31.63 Favored Pre-proline 0 C--N 1.332 -0.182 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -44.3 124.02 4.8 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.851 2.367 . . . . 0.0 112.309 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -41.38 136.23 1.83 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.454 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.17 -18.44 44.29 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.569 2.18 . . . . 0.0 112.571 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.1 p -57.43 -36.33 71.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 110.959 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.2 35.82 6.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.489 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -90.07 -73.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.32 -39.23 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.415 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -79.99 -168.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 110.815 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -105.64 173.26 6.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.505 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -54.91 -66.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.319 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.17 -27.52 46.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.192 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.408 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 6.6 mt-30 -95.22 9.42 39.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.542 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.41 -71.25 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.081 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.455 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.484 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -56.66 -14.15 3.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.31 147.21 32.94 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.825 0.345 . . . . 0.0 110.697 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.66 118.4 3.73 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.473 2.115 . . . . 0.0 112.292 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.474 ' HG ' ' HG ' ' A' ' 10' ' ' CYS . 33.7 t -35.25 134.69 0.46 Allowed Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.594 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.38 -17.75 55.12 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.604 2.203 . . . . 0.0 112.799 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.474 ' HG ' ' HG ' ' A' ' 8' ' ' CYS . 21.9 p -58.53 -27.92 64.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.06 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.94 33.05 24.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.628 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -90.43 -40.08 12.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 110.837 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.17 -5.13 6.38 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.794 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -112.78 149.14 33.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.889 0.376 . . . . 0.0 110.969 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 160.95 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.763 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.484 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -51.55 -64.32 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.017 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -23.16 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.404 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -99.28 8.84 44.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.658 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.33 -69.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.755 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 m170 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.702 0.287 . . . . 0.0 111.347 -179.581 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.484 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -72.04 0.37 9.63 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.792 0.294 . . . . 0.0 111.792 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -107.54 145.16 30.71 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.619 0.247 . . . . 0.0 110.632 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.4 Cg_endo -44.13 122.96 3.93 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.944 2.429 . . . . 0.0 112.309 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.1 t -41.65 135.64 2.04 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.425 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.95 -23.81 53.65 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.537 2.158 . . . . 0.0 112.465 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.4 p -59.94 -41.04 90.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 110.816 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.07 39.41 5.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.635 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -90.11 -39.89 12.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.934 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.4 -30.59 2.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.396 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.24 140.37 31.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 0.0 110.773 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -58.8 169.56 0.97 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.734 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.484 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -48.31 -65.67 0.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.796 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -32.7 33.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.8 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.452 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 10.8 mm-40 -93.72 13.65 21.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.626 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.69 -70.31 0.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.278 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.7 m170 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.485 179.532 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -70.9 0.15 7.92 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -108.69 145.61 31.99 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 120.652 0.263 . . . . 0.0 110.515 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -44.47 123.42 4.55 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.853 2.369 . . . . 0.0 112.247 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 t -41.37 135.52 1.89 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.481 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.3 -22.24 25.79 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.657 2.238 . . . . 0.0 112.491 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.9 p -58.37 -32.33 68.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.3 36.95 19.4 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.583 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -90.17 -44.61 9.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 0.0 110.943 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.72 -27.37 1.63 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -95.92 152.19 18.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -71.8 165.99 22.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.486 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.23 -67.47 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.224 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -23.02 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.43 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.18 8.54 44.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.577 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.37 -70.02 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.76 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.4 m170 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.771 0.319 . . . . 0.0 111.282 -179.558 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -90.36 0.72 57.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.659 0.266 . . . . 0.0 111.693 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -96.52 145.65 29.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.692 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 Cg_endo -41.09 117.68 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.095 2.53 . . . . 0.0 112.53 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 t -40.21 136.15 1.36 Allowed Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.488 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.95 -23.04 32.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.661 2.241 . . . . 0.0 112.64 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.8 p -58.68 -30.82 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.957 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.02 35.08 25.24 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.655 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -90.28 -35.81 15.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.941 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.62 -24.97 3.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.514 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.46 134.61 35.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.783 0.325 . . . . 0.0 111.03 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -61.73 164.62 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.776 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.61 -60.74 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.522 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.407 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 7.6 pttt -52.12 -32.03 33.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.476 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.431 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 2.4 mm-40 -89.86 4.95 48.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.46 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.0 t -150.2 -120.57 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.269 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 m170 . . . . . 0 C--O 1.231 0.105 0 O-C-N 122.188 -0.32 . . . . 0.0 111.286 -179.813 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.425 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -65.96 -5.59 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.32 145.46 30.48 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.68 0.276 . . . . 0.0 110.643 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.75 120.96 4.43 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.823 2.349 . . . . 0.0 112.229 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 t -38.24 134.11 0.92 Allowed Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.591 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.22 -20.69 63.2 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.596 2.197 . . . . 0.0 112.695 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.7 p -58.59 -32.44 68.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.44 35.58 8.57 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.544 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.7 p -90.1 -39.72 12.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.96 -27.62 3.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.47 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.45 144.03 26.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.879 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -60.26 163.22 5.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -46.34 -64.68 0.7 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.307 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.44 -25.99 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.268 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -94.37 5.87 50.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.614 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.16 -70.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.741 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.459 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 1.4 m80 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 111.241 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.789 0.328 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.469 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.6 p -81.03 146.09 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.227 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.97 96.22 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.479 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 4.1 ttt85 -47.48 -28.19 2.08 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -83.75 0.58 46.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.648 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -102.63 145.42 30.5 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.5 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.7 Cg_endo -42.03 119.59 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.157 2.571 . . . . 0.0 112.463 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -43.25 135.15 3.2 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.51 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.59 -18.87 42.15 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.669 2.246 . . . . 0.0 112.568 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.456 ' HB3' ' CE1' ' A' ' 20' ' ' HIS . 30.2 p -56.21 -27.62 55.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.771 0.32 . . . . 0.0 111.094 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.55 31.93 28.99 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.614 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -90.44 -46.41 8.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.78 -27.99 2.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.383 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -88.99 145.28 25.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 110.746 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -59.91 167.75 2.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.539 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.475 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -47.16 -68.92 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.347 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -22.69 18.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.292 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -90.27 6.3 43.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.725 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.19 -71.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.767 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' A' ' 10' ' ' CYS . 0.8 OUTLIER -93.66 -48.77 6.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.731 0.3 . . . . 0.0 111.342 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.77 -28.78 2.78 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.96 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.796 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.459 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.5 p -100.87 153.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.203 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -72.0 81.0 0.57 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.117 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.485 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.97 -29.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.84 -0.34 8.87 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.8 t70 -105.52 145.76 31.45 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.591 0.234 . . . . 0.0 110.685 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 Cg_endo -44.82 121.6 3.56 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.947 2.431 . . . . 0.0 112.282 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.6 t -41.25 134.26 1.92 Allowed Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.478 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.17 -17.47 52.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.564 2.176 . . . . 0.0 112.656 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.1 p -56.73 -29.59 62.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.78 0.324 . . . . 0.0 110.951 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.92 31.89 14.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.573 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -90.21 -62.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.39 -27.43 0.49 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -93.63 145.97 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.954 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.5 166.03 3.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.694 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.485 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -47.14 -70.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.272 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -24.08 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.554 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -99.78 15.41 27.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.853 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.32 -75.16 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.537 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -125.17 1.46 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.469 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . -56.19 -25.35 47.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.679 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.5 mttt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.85 0.357 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.4 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 13.2 p -101.53 144.56 12.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.17 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 5' ' ' ASN . . . -70.81 80.29 0.45 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.057 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.463 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -32.02 -35.46 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 3' ' ' GLY . 15.3 t-20 -57.85 -13.22 3.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -96.24 144.99 28.78 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.691 0.282 . . . . 0.0 110.626 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.37 119.01 3.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.677 2.251 . . . . 0.0 112.129 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.1 t -35.35 134.85 0.47 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.747 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 -20.41 50.85 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.606 2.204 . . . . 0.0 112.665 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.8 p -56.35 -29.51 61.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 111.023 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.63 36.37 16.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 p -90.15 -54.1 4.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.64 -26.69 0.84 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.611 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -97.52 162.84 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -72.12 166.55 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.948 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -50.07 -54.64 19.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.079 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -11.11 54.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.576 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -100.09 -21.1 15.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -119.96 -70.35 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -87.79 -74.85 0.43 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.716 0.293 . . . . 0.0 111.503 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.62 -29.63 1.95 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.046 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.888 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.846 0.355 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 3' ' ' GLY . 12.3 p -88.67 155.76 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.468 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -73.95 80.03 0.84 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.066 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.514 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.38 -30.14 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -71.69 0.24 9.25 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.3 t70 -105.66 145.41 30.8 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.727 0.298 . . . . 0.0 110.622 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 Cg_endo -44.23 121.8 3.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.952 2.435 . . . . 0.0 112.338 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -40.86 134.34 1.7 Allowed Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.507 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -60.65 -17.27 48.22 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.543 2.162 . . . . 0.0 112.679 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.7 p -56.9 -27.43 60.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.341 . . . . 0.0 111.054 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.25 29.5 19.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.553 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.5 p -90.2 -58.38 2.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.975 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.79 -28.66 1.29 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.396 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.97 131.88 34.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.802 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -53.7 161.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.022 0.439 . . . . 0.0 111.214 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.514 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.09 -67.42 0.29 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.946 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -49.53 -25.34 2.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.095 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.49 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -98.02 8.38 44.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.32 -71.47 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.798 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -97.39 -53.3 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.215 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.59 -30.29 2.13 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.035 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.946 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.859 0.362 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.3 p -121.7 144.89 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.17 98.76 0.15 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.27 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.474 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 34.7 ttt180 -49.3 -27.81 4.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -89.19 0.44 56.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.392 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -98.8 145.68 30.35 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.619 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.1 Cg_endo -41.19 118.35 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.02 2.48 . . . . 0.0 112.457 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.7 t -39.19 134.41 1.12 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.505 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.04 -20.28 60.02 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.479 2.119 . . . . 0.0 112.485 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -57.27 -29.93 64.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.023 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.77 32.85 12.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.584 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -90.24 -40.11 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 110.926 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.17 -34.71 2.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.494 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 145.69 28.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.657 0.265 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.36 167.35 2.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.527 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.474 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.19 -70.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.26 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -23.06 9.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.448 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -92.8 10.08 32.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.853 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.37 -74.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.312 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -99.54 -27.18 13.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.716 0.293 . . . . 0.0 111.708 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.25 -24.02 9.28 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.994 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.126 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.828 0.346 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.4 p -124.95 147.49 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.251 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.94 98.67 0.17 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.132 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 2.5 ttt85 -48.17 -28.51 3.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -85.95 0.13 54.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.688 0.28 . . . . 0.0 111.492 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.82 146.23 31.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 97.4 Cg_exo -41.9 119.23 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.737 2.291 . . . . 0.0 112.521 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 t -40.71 135.33 1.58 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.512 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.79 -20.72 36.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.565 2.177 . . . . 0.0 112.514 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.5 p -57.77 -27.66 63.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 111.001 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.02 32.91 30.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.574 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 p -90.35 -31.8 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.59 -27.26 5.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -90.3 143.72 26.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.713 0.292 . . . . 0.0 110.801 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -58.82 172.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.851 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.478 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -53.78 -68.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.195 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 9.7 pttp -54.59 -23.14 15.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.207 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.82 7.56 36.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.942 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.07 -71.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.785 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -105.76 -44.84 4.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.731 0.301 . . . . 0.0 111.32 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.98 -25.25 16.4 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.669 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.425 ' N ' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.054 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.88 0.371 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.46 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.0 p -87.31 150.1 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.52 95.6 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.194 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 8.6 ttp-105 -48.05 -27.36 2.24 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -87.16 0.27 55.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.662 0.268 . . . . 0.0 111.55 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.16 146.44 31.95 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.522 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 85.6 Cg_exo -41.41 118.94 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.776 2.317 . . . . 0.0 112.565 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 t -39.6 135.27 1.22 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.558 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.31 -21.12 27.83 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.656 2.237 . . . . 0.0 112.557 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -57.05 -25.57 58.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.35 31.71 45.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.668 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -90.29 -33.83 15.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.53 -25.62 4.47 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -89.56 147.14 24.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -67.75 168.0 12.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.676 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -51.9 -64.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.188 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -51.72 -29.02 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 0.0 111.094 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.0 6.62 41.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.55 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.4 t -150.29 -120.21 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.476 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.3 m170 -62.93 -18.76 63.52 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.05 -27.2 6.65 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.803 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.811 0.339 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.476 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 15.0 p -121.39 147.41 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.56 97.35 0.14 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.334 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.483 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 14.5 ttt180 -47.67 -28.65 2.51 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.58 0.47 54.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.772 0.32 . . . . 0.0 111.637 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.05 145.62 30.73 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.647 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.7 Cg_endo -42.12 119.41 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.054 2.503 . . . . 0.0 112.429 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 t -39.59 134.48 1.26 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.559 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.44 -20.43 56.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.615 2.21 . . . . 0.0 112.545 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.1 p -57.88 -30.59 65.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.998 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.67 34.01 14.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.516 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.2 m -90.2 -44.14 9.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.06 -37.5 1.64 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.408 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -83.88 145.96 28.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.768 0.318 . . . . 0.0 110.737 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.69 171.47 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.571 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.483 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -50.15 -71.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -52.36 -26.07 11.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 0.0 111.272 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -92.43 10.65 29.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.76 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.33 -72.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.142 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -116.45 -34.98 4.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.652 0.263 . . . . 0.0 111.468 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.11 -29.61 1.61 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.986 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.401 ' HB3' ' NH1' ' A' ' 22' ' ' ARG . 2.4 mtm105 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.889 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.752 0.311 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.49 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.6 p -84.34 148.12 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.72 96.3 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.206 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.528 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 31.7 ttt180 -47.52 -27.7 1.9 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -87.32 0.64 55.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.531 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -102.66 145.44 30.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.665 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.4 Cg_endo -40.91 119.8 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.131 2.554 . . . . 0.0 112.625 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.6 t -40.55 134.71 1.58 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.505 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.05 -18.38 61.32 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.535 2.156 . . . . 0.0 112.587 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.4 p -57.71 -30.64 65.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.745 0.307 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.79 33.52 11.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.551 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 m -90.03 -33.97 16.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.3 -27.68 4.71 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.438 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -91.55 162.96 14.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.768 0.318 . . . . 0.0 110.777 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 3.6 mmtm -74.23 179.79 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -61.79 -65.77 0.64 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.57 -23.72 42.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.961 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 1.3 tm0? -89.82 2.8 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.591 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.22 -70.1 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.659 0.266 . . . . 0.0 110.95 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 22' ' ' ARG . 8.7 m170 -94.08 -86.17 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.451 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.435 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 50.56 -84.05 0.01 OUTLIER Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.081 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 20' ' ' HIS . 17.4 ptm180 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.939 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.1 pttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.77 0.319 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.5 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.5 p -106.96 142.92 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.7 97.59 0.12 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.329 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.468 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 30.7 ttt-85 -47.55 -28.59 2.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -85.49 0.64 51.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.583 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.7 145.43 30.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.705 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.0 Cg_exo -40.65 118.96 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.171 2.581 . . . . 0.0 112.48 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.463 ' HG ' ' HG ' ' A' ' 10' ' ' CYS . 23.4 t -43.4 134.44 3.42 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.445 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.43 -17.05 58.31 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 112.788 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.463 ' HG ' ' HG ' ' A' ' 8' ' ' CYS . 20.3 p -56.74 -30.3 63.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 0.0 111.122 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.42 32.23 9.7 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.665 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.9 p -90.2 -61.46 1.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.375 . . . . 0.0 110.861 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.84 -28.0 0.74 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.549 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mtmm -94.84 141.07 29.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.758 0.313 . . . . 0.0 110.99 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -54.94 164.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.5 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -44.77 -59.82 2.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.825 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HB3' ' NH1' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -55.71 -35.03 65.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.55 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -90.34 12.24 18.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.825 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.78 -70.05 0.18 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.369 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' ARG . 10.3 m170 -99.65 -85.2 0.4 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.487 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.427 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 50.74 -84.13 0.01 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.879 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.975 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.96 0.41 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 3' ' ' GLY . 12.8 p -106.17 158.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.15 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -71.72 79.49 0.58 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.382 -0.914 . . . . 0.0 111.335 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.493 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.38 -30.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.38 -0.26 7.88 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.5 t70 -106.34 145.12 30.35 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.668 0.271 . . . . 0.0 110.579 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.7 Cg_endo -45.29 122.45 4.57 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.808 2.339 . . . . 0.0 112.185 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.6 t -40.27 134.37 1.5 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.417 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.74 -16.79 46.03 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.576 2.184 . . . . 0.0 112.786 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -57.1 -29.2 63.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.963 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.82 31.93 14.11 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.531 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 t -90.31 -50.7 5.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.03 -27.94 1.86 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -90.26 159.94 16.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -76.17 163.63 26.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.493 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.32 -64.91 0.66 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.128 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -24.28 36.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.885 0.374 . . . . 0.0 110.823 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.9 1.61 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.521 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.39 -69.95 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.684 0.278 . . . . 0.0 111.017 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.51 ' O ' ' N ' ' A' ' 22' ' ' ARG . 7.0 m170 -91.08 -83.99 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.273 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.431 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 49.65 -84.03 0.01 OUTLIER Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.09 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 20' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.894 0.378 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.4 p -125.43 154.17 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.145 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -62.62 94.97 0.11 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.233 178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 2.1 ttm180 -47.72 -28.17 2.33 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -88.31 0.3 56.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.633 0.254 . . . . 0.0 111.612 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -100.93 146.1 31.55 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.578 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.5 Cg_endo -42.33 119.39 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.987 2.458 . . . . 0.0 112.25 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 t -39.23 134.4 1.14 Allowed Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.599 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.1 -20.93 63.57 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.557 2.171 . . . . 0.0 112.473 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.1 p -55.41 -27.9 50.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.034 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.36 31.45 19.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.557 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.4 m -90.21 -41.99 11.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.05 -26.47 3.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.459 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -91.38 131.85 36.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.785 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -51.39 162.61 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.05 0.452 . . . . 0.0 111.184 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.489 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -44.54 -66.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.945 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -22.44 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.845 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.436 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 3.8 mm100 -93.99 2.54 56.06 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.3 t -150.05 -71.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.861 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.4 m170 -88.2 -55.56 3.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 111.254 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.32 -34.19 3.3 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.131 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.791 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.7 mptt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.861 0.362 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.47 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.3 p -88.73 139.43 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.8 99.65 0.14 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.303 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.46 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 9.2 ttt180 -48.08 -28.2 2.74 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.15 0.24 52.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.692 0.282 . . . . 0.0 111.406 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.18 145.57 30.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.505 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.0 Cg_endo -41.58 119.52 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.139 2.559 . . . . 0.0 112.473 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 t -42.32 136.24 2.38 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.384 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.23 -22.47 26.19 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.604 2.203 . . . . 0.0 112.467 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.4 p -59.31 -34.99 72.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.17 38.6 18.14 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.636 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 t -90.29 -36.73 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.343 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.27 -37.28 1.5 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.447 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.65 160.04 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.707 0.289 . . . . 0.0 110.703 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -72.15 179.96 3.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.611 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.47 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -55.61 -64.1 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' HA ' ' N ' ' A' ' 22' ' ' ARG . 3.0 pttp -60.08 -16.87 35.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.338 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -89.46 -20.11 24.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.629 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 t -123.06 -79.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -86.55 -59.22 2.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.736 0.303 . . . . 0.0 111.543 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -46.53 -32.09 5.36 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.87 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' N ' ' HA ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.112 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.9 145.16 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.277 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 5' ' ' ASN . . . -69.87 79.26 0.37 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.097 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -33.17 -34.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 3' ' ' GLY . 0.4 OUTLIER -56.08 -16.24 4.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.581 0.229 . . . . 0.0 111.46 179.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -91.87 144.83 29.92 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.671 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -48.09 117.62 2.64 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.722 2.281 . . . . 0.0 112.167 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.8 t -34.09 134.55 0.37 Allowed Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.811 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.62 -16.7 49.93 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.65 2.233 . . . . 0.0 112.808 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.0 p -56.88 -25.04 55.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.712 0.291 . . . . 0.0 111.137 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.94 28.58 31.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.693 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -90.36 -46.28 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.06 -26.83 3.08 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -87.85 144.84 26.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 158.24 17.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.693 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.6 OUTLIER -46.34 -61.15 1.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.259 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -55.34 -22.95 21.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.457 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -98.67 8.98 44.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.797 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.17 -69.15 0.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.597 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.462 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.1 m170 -93.05 -58.14 2.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.322 . . . . 0.0 111.185 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.82 -26.31 8.03 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.78 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.908 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.5 mttt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.846 0.355 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 3' ' ' GLY . 12.7 p -121.23 157.82 24.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.239 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.505 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -80.76 85.36 1.37 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.397 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.505 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -37.68 -29.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -69.66 -0.48 6.96 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.6 t70 -109.01 145.39 31.63 Favored Pre-proline 0 C--N 1.332 -0.182 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -44.3 124.02 4.8 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.851 2.367 . . . . 0.0 112.309 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 42.5 t -41.38 136.23 1.83 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.454 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.17 -18.44 44.29 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.569 2.18 . . . . 0.0 112.571 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.1 p -57.43 -36.33 71.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 110.959 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.2 35.82 6.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.489 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -90.07 -73.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.32 -39.23 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.415 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -79.99 -168.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 110.815 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -105.64 173.26 6.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.505 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -54.91 -66.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.319 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.17 -27.52 46.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.192 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.408 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 6.6 mt-30 -95.22 9.42 39.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.542 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.41 -71.25 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.081 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.487 ' O ' ' N ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -95.93 -84.05 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.455 179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.438 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 50.52 -84.32 0.01 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.002 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 20' ' ' HIS . 77.5 mtt180 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.889 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.829 0.347 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p -73.13 145.73 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.202 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 5' ' ' ASN . . . -69.54 81.41 0.3 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.316 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.484 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -32.53 -35.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 3' ' ' GLY . 62.7 t30 -56.66 -14.15 3.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.31 147.21 32.94 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.825 0.345 . . . . 0.0 110.697 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.66 118.4 3.73 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.473 2.115 . . . . 0.0 112.292 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.474 ' HG ' ' HG ' ' A' ' 10' ' ' CYS . 33.7 t -35.25 134.69 0.46 Allowed Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.594 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.38 -17.75 55.12 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.604 2.203 . . . . 0.0 112.799 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.474 ' HG ' ' HG ' ' A' ' 8' ' ' CYS . 21.9 p -58.53 -27.92 64.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.06 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.94 33.05 24.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.628 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -90.43 -40.08 12.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 110.837 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.17 -5.13 6.38 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.794 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -112.78 149.14 33.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.889 0.376 . . . . 0.0 110.969 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 160.95 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.763 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.484 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -51.55 -64.32 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.017 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -23.16 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.404 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -99.28 8.84 44.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.658 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.33 -69.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.755 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -99.07 -54.48 2.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.702 0.287 . . . . 0.0 111.347 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.29 -29.19 1.61 Allowed Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.986 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.889 179.878 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.5 HG22 ' N ' ' A' ' 3' ' ' GLY . 14.4 p -113.55 157.92 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.231 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -78.24 83.57 1.19 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.258 178.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.484 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -37.23 -29.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -72.04 0.37 9.63 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.792 0.294 . . . . 0.0 111.792 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 3' ' ' GLY . 6.2 t70 -107.54 145.16 30.71 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.619 0.247 . . . . 0.0 110.632 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.4 Cg_endo -44.13 122.96 3.93 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.944 2.429 . . . . 0.0 112.309 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.1 t -41.65 135.64 2.04 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.425 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.95 -23.81 53.65 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.537 2.158 . . . . 0.0 112.465 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.4 p -59.94 -41.04 90.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 110.816 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.07 39.41 5.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.635 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -90.11 -39.89 12.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.934 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.4 -30.59 2.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.396 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.24 140.37 31.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 0.0 110.773 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -58.8 169.56 0.97 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.734 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.484 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -48.31 -65.67 0.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.796 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -32.7 33.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.8 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.452 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 10.8 mm-40 -93.72 13.65 21.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.626 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.69 -70.31 0.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.278 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.487 ' O ' ' N ' ' A' ' 22' ' ' ARG . 10.7 m170 -100.24 -86.86 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.485 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 51.58 -84.25 0.01 OUTLIER Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.826 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 20' ' ' HIS . 6.4 mtt-85 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.821 0.343 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 3' ' ' GLY . 13.3 p -106.14 158.42 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.23 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.507 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -76.73 82.33 1.08 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.273 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -37.42 -29.46 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -70.9 0.15 7.92 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 3' ' ' GLY . 7.2 t70 -108.69 145.61 31.99 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 120.652 0.263 . . . . 0.0 110.515 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -44.47 123.42 4.55 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.853 2.369 . . . . 0.0 112.247 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 t -41.37 135.52 1.89 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.481 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.3 -22.24 25.79 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.657 2.238 . . . . 0.0 112.491 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.9 p -58.37 -32.33 68.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.3 36.95 19.4 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.583 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -90.17 -44.61 9.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 0.0 110.943 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.72 -27.37 1.63 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -95.92 152.19 18.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -71.8 165.99 22.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.486 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.23 -67.47 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.224 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -23.02 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.43 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.18 8.54 44.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.577 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.37 -70.02 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.76 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -98.55 -52.99 3.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.771 0.319 . . . . 0.0 111.282 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.6 -28.2 2.37 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.016 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.903 179.954 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.828 0.347 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.488 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.5 p -116.33 145.87 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.144 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.03 96.03 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.237 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -47.74 -28.14 2.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -90.36 0.72 57.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.659 0.266 . . . . 0.0 111.693 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -96.52 145.65 29.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.692 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 Cg_endo -41.09 117.68 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.095 2.53 . . . . 0.0 112.53 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 t -40.21 136.15 1.36 Allowed Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.488 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.95 -23.04 32.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.661 2.241 . . . . 0.0 112.64 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.8 p -58.68 -30.82 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.957 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.02 35.08 25.24 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.655 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -90.28 -35.81 15.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.941 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.62 -24.97 3.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.514 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.46 134.61 35.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.783 0.325 . . . . 0.0 111.03 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -61.73 164.62 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.776 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.61 -60.74 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.522 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 7.6 pttt -52.12 -32.03 33.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.476 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.431 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 2.4 mm-40 -89.86 4.95 48.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.46 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.0 t -150.2 -120.57 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.269 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -51.98 -42.64 63.1 Favored 'General case' 0 C--O 1.231 0.105 0 O-C-N 122.188 -0.32 . . . . 0.0 111.286 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.85 -27.91 59.89 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.598 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.846 0.355 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 13.3 p -125.0 150.78 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.191 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.53 80.01 0.43 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.306 -0.949 . . . . 0.0 111.045 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -35.57 -31.01 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.715 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -65.96 -5.59 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.32 145.46 30.48 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.68 0.276 . . . . 0.0 110.643 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.75 120.96 4.43 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.823 2.349 . . . . 0.0 112.229 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 t -38.24 134.11 0.92 Allowed Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.591 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.22 -20.69 63.2 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.596 2.197 . . . . 0.0 112.695 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.7 p -58.59 -32.44 68.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.44 35.58 8.57 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.544 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.7 p -90.1 -39.72 12.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.96 -27.62 3.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.47 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.45 144.03 26.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.879 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -60.26 163.22 5.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -46.34 -64.68 0.7 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.307 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.414 ' HA ' ' N ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -53.44 -25.99 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.268 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -94.37 5.87 50.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.614 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.16 -70.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.741 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.459 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 1.4 m80 -98.58 -59.87 1.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 111.241 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.95 -27.49 5.02 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.782 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.414 ' N ' ' HA ' ' A' ' 17' ' ' LYS . 17.0 mmt180 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.98 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 4.1 ttt85 . . . . . 0 N--CA 1.457 -0.114 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -83.75 0.58 46.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.648 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -102.63 145.42 30.5 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.5 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.7 Cg_endo -42.03 119.59 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.157 2.571 . . . . 0.0 112.463 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -43.25 135.15 3.2 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.51 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.59 -18.87 42.15 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.669 2.246 . . . . 0.0 112.568 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.2 p -56.21 -27.62 55.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.771 0.32 . . . . 0.0 111.094 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.55 31.93 28.99 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.614 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -90.44 -46.41 8.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.78 -27.99 2.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.383 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -88.99 145.28 25.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 110.746 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -59.91 167.75 2.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.539 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.475 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -47.16 -68.92 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.347 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -22.69 18.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.292 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -90.27 6.3 43.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.725 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.19 -71.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.767 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.731 0.3 . . . . 0.0 111.342 -179.457 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.485 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -70.84 -0.34 8.87 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -105.52 145.76 31.45 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.591 0.234 . . . . 0.0 110.685 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 Cg_endo -44.82 121.6 3.56 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.947 2.431 . . . . 0.0 112.282 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.6 t -41.25 134.26 1.92 Allowed Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.478 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.17 -17.47 52.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.564 2.176 . . . . 0.0 112.656 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.1 p -56.73 -29.59 62.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.78 0.324 . . . . 0.0 110.951 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.92 31.89 14.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.573 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -90.21 -62.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.39 -27.43 0.49 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -93.63 145.97 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.954 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.5 166.03 3.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.694 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.485 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -47.14 -70.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.272 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -24.08 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.554 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -99.78 15.41 27.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.853 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.32 -75.16 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.537 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.5 m80 . . . . . 0 C--N 1.331 -0.235 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.136 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.463 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -57.85 -13.22 3.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -96.24 144.99 28.78 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.691 0.282 . . . . 0.0 110.626 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.37 119.01 3.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.677 2.251 . . . . 0.0 112.129 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.1 t -35.35 134.85 0.47 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.747 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 -20.41 50.85 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.606 2.204 . . . . 0.0 112.665 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.8 p -56.35 -29.51 61.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 111.023 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.63 36.37 16.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 p -90.15 -54.1 4.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.64 -26.69 0.84 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.611 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -97.52 162.84 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -72.12 166.55 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.948 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -50.07 -54.64 19.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.079 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -11.11 54.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.576 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -100.09 -21.1 15.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -119.96 -70.35 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.3 m170 . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.716 0.293 . . . . 0.0 111.503 -179.434 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.514 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -71.69 0.24 9.25 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -105.66 145.41 30.8 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.727 0.298 . . . . 0.0 110.622 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 Cg_endo -44.23 121.8 3.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.952 2.435 . . . . 0.0 112.338 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -40.86 134.34 1.7 Allowed Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.507 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -60.65 -17.27 48.22 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.543 2.162 . . . . 0.0 112.679 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.7 p -56.9 -27.43 60.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.341 . . . . 0.0 111.054 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.25 29.5 19.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.553 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.5 p -90.2 -58.38 2.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.975 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.79 -28.66 1.29 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.396 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.97 131.88 34.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.802 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -53.7 161.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.022 0.439 . . . . 0.0 111.214 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.514 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.09 -67.42 0.29 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.946 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -49.53 -25.34 2.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.095 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.49 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -98.02 8.38 44.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.32 -71.47 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.798 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.2 m170 . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.215 -179.621 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.474 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 34.7 ttt180 . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -89.19 0.44 56.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.392 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -98.8 145.68 30.35 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.619 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.1 Cg_endo -41.19 118.35 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.02 2.48 . . . . 0.0 112.457 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.7 t -39.19 134.41 1.12 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.505 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.04 -20.28 60.02 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.479 2.119 . . . . 0.0 112.485 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -57.27 -29.93 64.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.023 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.77 32.85 12.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.584 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -90.24 -40.11 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 110.926 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.17 -34.71 2.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.494 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 145.69 28.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.657 0.265 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.36 167.35 2.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.527 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.474 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.19 -70.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.26 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -23.06 9.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.448 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -92.8 10.08 32.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.853 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.37 -74.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.312 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.1 m170 . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.716 0.293 . . . . 0.0 111.708 -179.096 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 2.5 ttt85 . . . . . 0 N--CA 1.456 -0.129 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -85.95 0.13 54.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.688 0.28 . . . . 0.0 111.492 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.82 146.23 31.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 97.4 Cg_exo -41.9 119.23 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.737 2.291 . . . . 0.0 112.521 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 t -40.71 135.33 1.58 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.512 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.79 -20.72 36.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.565 2.177 . . . . 0.0 112.514 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.5 p -57.77 -27.66 63.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 111.001 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.02 32.91 30.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.574 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 p -90.35 -31.8 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.59 -27.26 5.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -90.3 143.72 26.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.713 0.292 . . . . 0.0 110.801 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -58.82 172.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.851 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.478 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -53.78 -68.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.195 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 9.7 pttp -54.59 -23.14 15.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.207 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.82 7.56 36.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.942 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.07 -71.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.785 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.6 m80 . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.731 0.301 . . . . 0.0 111.32 -179.729 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 8.6 ttp-105 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -87.16 0.27 55.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.662 0.268 . . . . 0.0 111.55 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.16 146.44 31.95 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.522 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 85.6 Cg_exo -41.41 118.94 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.776 2.317 . . . . 0.0 112.565 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 t -39.6 135.27 1.22 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.558 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.31 -21.12 27.83 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.656 2.237 . . . . 0.0 112.557 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -57.05 -25.57 58.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.35 31.71 45.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.668 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -90.29 -33.83 15.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.53 -25.62 4.47 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -89.56 147.14 24.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -67.75 168.0 12.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.676 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -51.9 -64.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.188 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -51.72 -29.02 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 0.0 111.094 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.0 6.62 41.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.55 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.4 t -150.29 -120.21 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.476 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.3 m170 . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.262 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.483 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 14.5 ttt180 . . . . . 0 CA--C 1.528 0.13 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.58 0.47 54.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.772 0.32 . . . . 0.0 111.637 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.05 145.62 30.73 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.647 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.7 Cg_endo -42.12 119.41 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.054 2.503 . . . . 0.0 112.429 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 t -39.59 134.48 1.26 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.559 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.44 -20.43 56.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.615 2.21 . . . . 0.0 112.545 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.1 p -57.88 -30.59 65.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.998 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.67 34.01 14.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.516 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.2 m -90.2 -44.14 9.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.06 -37.5 1.64 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.408 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -83.88 145.96 28.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.768 0.318 . . . . 0.0 110.737 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.69 171.47 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.571 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.483 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -50.15 -71.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -52.36 -26.07 11.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 0.0 111.272 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -92.43 10.65 29.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.76 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.33 -72.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.142 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.7 m170 . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.652 0.263 . . . . 0.0 111.468 -179.384 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.528 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 31.7 ttt180 . . . . . 0 N--CA 1.456 -0.132 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -87.32 0.64 55.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.531 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -102.66 145.44 30.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.665 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.4 Cg_endo -40.91 119.8 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.131 2.554 . . . . 0.0 112.625 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.6 t -40.55 134.71 1.58 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.505 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.05 -18.38 61.32 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.535 2.156 . . . . 0.0 112.587 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.4 p -57.71 -30.64 65.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.745 0.307 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.79 33.52 11.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.551 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 m -90.03 -33.97 16.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.3 -27.68 4.71 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.438 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -91.55 162.96 14.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.768 0.318 . . . . 0.0 110.777 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 3.6 mmtm -74.23 179.79 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -61.79 -65.77 0.64 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.57 -23.72 42.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.961 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 1.3 tm0? -89.82 2.8 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.591 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.22 -70.1 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.659 0.266 . . . . 0.0 110.95 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.7 m170 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.451 179.541 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.468 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 30.7 ttt-85 . . . . . 0 C--O 1.231 0.082 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -85.49 0.64 51.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.583 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.7 145.43 30.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.705 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.0 Cg_exo -40.65 118.96 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.171 2.581 . . . . 0.0 112.48 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.463 ' HG ' ' HG ' ' A' ' 10' ' ' CYS . 23.4 t -43.4 134.44 3.42 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.445 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.43 -17.05 58.31 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 112.788 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.463 ' HG ' ' HG ' ' A' ' 8' ' ' CYS . 20.3 p -56.74 -30.3 63.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 0.0 111.122 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.42 32.23 9.7 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.665 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.9 p -90.2 -61.46 1.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.375 . . . . 0.0 110.861 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.84 -28.0 0.74 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.549 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mtmm -94.84 141.07 29.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.758 0.313 . . . . 0.0 110.99 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -54.94 164.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.468 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -44.77 -59.82 2.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.825 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HB3' ' NH1' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -55.71 -35.03 65.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.55 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -90.34 12.24 18.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.825 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.78 -70.05 0.18 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.369 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.46 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 10.3 m170 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.487 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.493 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.38 -0.26 7.88 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -106.34 145.12 30.35 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.668 0.271 . . . . 0.0 110.579 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.7 Cg_endo -45.29 122.45 4.57 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.808 2.339 . . . . 0.0 112.185 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.6 t -40.27 134.37 1.5 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.417 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.74 -16.79 46.03 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.576 2.184 . . . . 0.0 112.786 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -57.1 -29.2 63.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.963 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.82 31.93 14.11 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.531 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 t -90.31 -50.7 5.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.03 -27.94 1.86 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -90.26 159.94 16.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -76.17 163.63 26.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.493 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.32 -64.91 0.66 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.128 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -24.28 36.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.885 0.374 . . . . 0.0 110.823 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -89.9 1.61 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.521 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.39 -69.95 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.684 0.278 . . . . 0.0 111.017 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.407 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.0 m170 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.273 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 2.1 ttm180 . . . . . 0 C--O 1.231 0.121 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -88.31 0.3 56.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.633 0.254 . . . . 0.0 111.612 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -100.93 146.1 31.55 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.578 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.5 Cg_endo -42.33 119.39 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.987 2.458 . . . . 0.0 112.25 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 t -39.23 134.4 1.14 Allowed Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.599 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.1 -20.93 63.57 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.557 2.171 . . . . 0.0 112.473 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.1 p -55.41 -27.9 50.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.034 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.36 31.45 19.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.557 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.4 m -90.21 -41.99 11.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.05 -26.47 3.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.459 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -91.38 131.85 36.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.785 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -51.39 162.61 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.05 0.452 . . . . 0.0 111.184 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -44.54 -66.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.945 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -22.44 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.845 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.436 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 3.8 mm100 -93.99 2.54 56.06 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.3 t -150.05 -71.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.861 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.4 m170 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 111.254 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.46 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 9.2 ttt180 . . . . . 0 CA--C 1.528 0.108 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.15 0.24 52.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.692 0.282 . . . . 0.0 111.406 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.18 145.57 30.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.505 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.0 Cg_endo -41.58 119.52 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.139 2.559 . . . . 0.0 112.473 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 t -42.32 136.24 2.38 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.384 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.23 -22.47 26.19 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.604 2.203 . . . . 0.0 112.467 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.4 p -59.31 -34.99 72.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.17 38.6 18.14 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.636 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 t -90.29 -36.73 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.343 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.27 -37.28 1.5 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.447 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.65 160.04 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.707 0.289 . . . . 0.0 110.703 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -72.15 179.96 3.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.611 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.46 ' HB3' ' HA ' ' A' ' 4' ' ' ARG . 0.5 OUTLIER -55.61 -64.1 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -60.08 -16.87 35.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.338 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -89.46 -20.11 24.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.629 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 t -123.06 -79.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 m80 . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.736 0.303 . . . . 0.0 111.543 -179.356 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.08 -16.24 4.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.581 0.229 . . . . 0.0 111.46 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -91.87 144.83 29.92 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.671 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -48.09 117.62 2.64 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.722 2.281 . . . . 0.0 112.167 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.8 t -34.09 134.55 0.37 Allowed Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.811 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.62 -16.7 49.93 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.65 2.233 . . . . 0.0 112.808 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.0 p -56.88 -25.04 55.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.712 0.291 . . . . 0.0 111.137 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.94 28.58 31.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.693 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -90.36 -46.28 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.06 -26.83 3.08 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -87.85 144.84 26.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 158.24 17.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.693 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.6 OUTLIER -46.34 -61.15 1.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.259 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -55.34 -22.95 21.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.457 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -98.67 8.98 44.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.797 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.17 -69.15 0.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.597 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.462 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.1 m170 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.322 . . . . 0.0 111.185 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.505 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -69.66 -0.48 6.96 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -109.01 145.39 31.63 Favored Pre-proline 0 C--N 1.332 -0.182 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -44.3 124.02 4.8 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.851 2.367 . . . . 0.0 112.309 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.414 ' HG ' ' HG ' ' A' ' 10' ' ' CYS . 42.5 t -41.38 136.23 1.83 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.454 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.17 -18.44 44.29 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.569 2.18 . . . . 0.0 112.571 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.414 ' HG ' ' HG ' ' A' ' 8' ' ' CYS . 25.1 p -57.43 -36.33 71.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 110.959 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.2 35.82 6.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.489 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -90.07 -73.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.32 -39.23 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.415 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -79.99 -168.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 110.815 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -105.64 173.26 6.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.505 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -54.91 -66.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.319 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.17 -27.52 46.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.192 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.408 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 34.5 mt-30 -95.22 9.42 39.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.542 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.41 -71.25 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.081 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 11.4 m170 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.455 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.484 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -56.66 -14.15 3.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.31 147.21 32.94 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.825 0.345 . . . . 0.0 110.697 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.66 118.4 3.73 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.473 2.115 . . . . 0.0 112.292 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.474 ' HG ' ' HG ' ' A' ' 10' ' ' CYS . 33.7 t -35.25 134.69 0.46 Allowed Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.594 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.38 -17.75 55.12 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.604 2.203 . . . . 0.0 112.799 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.474 ' HG ' ' HG ' ' A' ' 8' ' ' CYS . 21.9 p -58.53 -27.92 64.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.06 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.94 33.05 24.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.628 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -90.43 -40.08 12.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 110.837 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.17 -5.13 6.38 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.794 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -112.78 149.14 33.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.889 0.376 . . . . 0.0 110.969 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 160.95 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.763 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.484 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -51.55 -64.32 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.017 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -23.16 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.404 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -99.28 8.84 44.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.658 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.33 -69.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.755 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 m170 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.702 0.287 . . . . 0.0 111.347 -179.581 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.484 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -72.04 0.37 9.63 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.792 0.294 . . . . 0.0 111.792 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -107.54 145.16 30.71 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.619 0.247 . . . . 0.0 110.632 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.4 Cg_endo -44.13 122.96 3.93 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.944 2.429 . . . . 0.0 112.309 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.1 t -41.65 135.64 2.04 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.425 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.95 -23.81 53.65 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.537 2.158 . . . . 0.0 112.465 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.4 p -59.94 -41.04 90.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 110.816 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.07 39.41 5.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.635 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -90.11 -39.89 12.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.934 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.4 -30.59 2.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.396 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.24 140.37 31.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 0.0 110.773 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -58.8 169.56 0.97 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.734 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.484 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -48.31 -65.67 0.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.796 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -32.7 33.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.8 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.452 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 10.8 mm-40 -93.72 13.65 21.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.626 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.69 -70.31 0.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.278 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.7 m170 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.485 179.532 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.389 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -70.9 0.15 7.92 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -108.69 145.61 31.99 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 120.652 0.263 . . . . 0.0 110.515 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -44.47 123.42 4.55 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.853 2.369 . . . . 0.0 112.247 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 t -41.37 135.52 1.89 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.481 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.3 -22.24 25.79 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.657 2.238 . . . . 0.0 112.491 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.9 p -58.37 -32.33 68.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.3 36.95 19.4 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.583 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -90.17 -44.61 9.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 0.0 110.943 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.72 -27.37 1.63 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -95.92 152.19 18.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -71.8 165.99 22.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.486 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.23 -67.47 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.224 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -23.02 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.43 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.18 8.54 44.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.577 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.37 -70.02 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.76 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.4 m170 . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.771 0.319 . . . . 0.0 111.282 -179.558 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.133 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -90.36 0.72 57.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.659 0.266 . . . . 0.0 111.693 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -96.52 145.65 29.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.692 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 Cg_endo -41.09 117.68 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.095 2.53 . . . . 0.0 112.53 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 t -40.21 136.15 1.36 Allowed Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.488 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.95 -23.04 32.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.661 2.241 . . . . 0.0 112.64 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.8 p -58.68 -30.82 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.957 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.02 35.08 25.24 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.655 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -90.28 -35.81 15.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.941 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.62 -24.97 3.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.514 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.46 134.61 35.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.783 0.325 . . . . 0.0 111.03 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -61.73 164.62 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.776 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.61 -60.74 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.522 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.407 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 7.6 pttt -52.12 -32.03 33.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.476 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.431 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 2.4 mm-40 -89.86 4.95 48.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.46 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.0 t -150.2 -120.57 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.269 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 m170 . . . . . 0 C--O 1.231 0.105 0 O-C-N 122.188 -0.32 . . . . 0.0 111.286 -179.813 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.425 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -65.96 -5.59 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.32 145.46 30.48 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.68 0.276 . . . . 0.0 110.643 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.75 120.96 4.43 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.823 2.349 . . . . 0.0 112.229 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 t -38.24 134.11 0.92 Allowed Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.591 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.22 -20.69 63.2 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.596 2.197 . . . . 0.0 112.695 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.7 p -58.59 -32.44 68.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.44 35.58 8.57 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.544 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.7 p -90.1 -39.72 12.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.96 -27.62 3.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.47 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.45 144.03 26.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.879 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -60.26 163.22 5.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -46.34 -64.68 0.7 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.307 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -53.44 -25.99 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.268 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -94.37 5.87 50.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.614 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.16 -70.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.741 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.459 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 11.1 m170 . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 111.241 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.4 ttpp . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.789 0.328 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.469 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.6 p -81.03 146.09 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.227 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.97 96.22 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.479 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.475 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 4.1 ttt85 -47.48 -28.19 2.08 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -83.75 0.58 46.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.648 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -102.63 145.42 30.5 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.5 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.7 Cg_endo -42.03 119.59 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.157 2.571 . . . . 0.0 112.463 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.1 t -43.25 135.15 3.2 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.51 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.59 -18.87 42.15 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.669 2.246 . . . . 0.0 112.568 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.2 p -56.21 -27.62 55.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.771 0.32 . . . . 0.0 111.094 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.55 31.93 28.99 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.614 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -90.44 -46.41 8.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.78 -27.99 2.55 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.383 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -88.99 145.28 25.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.792 0.33 . . . . 0.0 110.746 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -59.91 167.75 2.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.539 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.475 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -47.16 -68.92 0.15 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.347 -179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -22.69 18.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.292 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -90.27 6.3 43.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.725 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.19 -71.4 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.767 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -93.66 -48.77 6.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.731 0.3 . . . . 0.0 111.342 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.77 -28.78 2.78 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.96 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.796 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.459 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.5 p -100.87 153.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.203 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -72.0 81.0 0.57 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.117 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.485 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -36.97 -29.99 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -70.84 -0.34 8.87 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.8 t70 -105.52 145.76 31.45 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.591 0.234 . . . . 0.0 110.685 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 Cg_endo -44.82 121.6 3.56 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.947 2.431 . . . . 0.0 112.282 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.6 t -41.25 134.26 1.92 Allowed Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.478 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.17 -17.47 52.65 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.564 2.176 . . . . 0.0 112.656 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.1 p -56.73 -29.59 62.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.78 0.324 . . . . 0.0 110.951 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.92 31.89 14.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.573 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 80.7 p -90.21 -62.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 110.913 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.39 -27.43 0.49 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.473 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -93.63 145.97 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.954 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.5 166.03 3.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.694 179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.485 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -47.14 -70.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.272 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.65 -24.08 3.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.554 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -99.78 15.41 27.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.853 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.32 -75.16 0.16 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.537 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -125.17 1.46 7.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.469 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . -56.19 -25.35 47.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.679 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.131 -0.937 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.5 mttt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.85 0.357 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.4 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 13.2 p -101.53 144.56 12.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.17 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 5' ' ' ASN . . . -70.81 80.29 0.45 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.057 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.463 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -32.02 -35.46 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 3' ' ' GLY . 15.3 t-20 -57.85 -13.22 3.97 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -96.24 144.99 28.78 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.691 0.282 . . . . 0.0 110.626 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -47.37 119.01 3.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.677 2.251 . . . . 0.0 112.129 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 40.1 t -35.35 134.85 0.47 Allowed Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.747 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 -20.41 50.85 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.606 2.204 . . . . 0.0 112.665 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.8 p -56.35 -29.51 61.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.781 0.324 . . . . 0.0 111.023 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.63 36.37 16.67 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.493 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.2 p -90.15 -54.1 4.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.812 0.339 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.64 -26.69 0.84 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.611 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -97.52 162.84 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.912 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -72.12 166.55 22.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.948 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.8 OUTLIER -50.07 -54.64 19.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.079 179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 -11.11 54.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.576 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -100.09 -21.1 15.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.654 0.264 . . . . 0.0 111.444 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -119.96 -70.35 0.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -87.79 -74.85 0.43 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.716 0.293 . . . . 0.0 111.503 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.62 -29.63 1.95 Allowed Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.046 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.888 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.846 0.355 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 3' ' ' GLY . 12.3 p -88.67 155.76 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.468 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -73.95 80.03 0.84 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.384 -0.912 . . . . 0.0 111.066 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.514 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.38 -30.14 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -71.69 0.24 9.25 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 3' ' ' GLY . 4.3 t70 -105.66 145.41 30.8 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.727 0.298 . . . . 0.0 110.622 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.8 Cg_endo -44.23 121.8 3.3 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.952 2.435 . . . . 0.0 112.338 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -40.86 134.34 1.7 Allowed Pre-proline 0 N--CA 1.464 0.234 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.507 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -60.65 -17.27 48.22 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.543 2.162 . . . . 0.0 112.679 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.7 p -56.9 -27.43 60.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.341 . . . . 0.0 111.054 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.25 29.5 19.58 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.553 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.5 p -90.2 -58.38 2.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.975 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.79 -28.66 1.29 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.396 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.97 131.88 34.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.802 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HG2' ' HB2' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -53.7 161.57 1.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.022 0.439 . . . . 0.0 111.214 -179.777 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.514 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.09 -67.42 0.29 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.946 -179.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -49.53 -25.34 2.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.486 . . . . 0.0 112.095 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.49 ' HB2' ' HG2' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -98.02 8.38 44.85 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.32 -71.47 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.798 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -97.39 -53.3 3.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 0.0 111.215 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.59 -30.29 2.13 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.035 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.946 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.859 0.362 . . . . 0.0 111.259 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.3 p -121.7 144.89 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.179 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.17 98.76 0.15 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.27 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.474 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 34.7 ttt180 -49.3 -27.81 4.21 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -89.19 0.44 56.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.392 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -98.8 145.68 30.35 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.619 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.1 Cg_endo -41.19 118.35 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.02 2.48 . . . . 0.0 112.457 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.7 t -39.19 134.41 1.12 Allowed Pre-proline 0 N--CA 1.465 0.296 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.505 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.04 -20.28 60.02 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.479 2.119 . . . . 0.0 112.485 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.7 p -57.27 -29.93 64.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.023 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.77 32.85 12.06 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.584 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -90.24 -40.11 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 110.926 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.17 -34.71 2.4 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.494 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.62 145.69 28.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.657 0.265 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.36 167.35 2.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.527 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.474 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.19 -70.09 0.1 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.26 -179.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -23.06 9.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.448 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -92.8 10.08 32.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.853 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.37 -74.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.312 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -99.54 -27.18 13.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.716 0.293 . . . . 0.0 111.708 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.25 -24.02 9.28 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.994 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.126 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.828 0.346 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.4 p -124.95 147.49 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.251 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.94 98.67 0.17 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.132 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 2.5 ttt85 -48.17 -28.51 3.01 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -85.95 0.13 54.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.688 0.28 . . . . 0.0 111.492 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -100.82 146.23 31.73 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.503 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 97.4 Cg_exo -41.9 119.23 1.11 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.737 2.291 . . . . 0.0 112.521 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 t -40.71 135.33 1.58 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.512 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.79 -20.72 36.71 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.565 2.177 . . . . 0.0 112.514 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.5 p -57.77 -27.66 63.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 111.001 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.02 32.91 30.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.574 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.6 p -90.35 -31.8 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.811 0.339 . . . . 0.0 110.964 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.59 -27.26 5.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.429 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 mttp -90.3 143.72 26.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.713 0.292 . . . . 0.0 110.801 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -58.82 172.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.851 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.478 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -53.78 -68.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.195 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.437 ' HB3' ' HG2' ' A' ' 4' ' ' ARG . 9.7 pttp -54.59 -23.14 15.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.207 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.82 7.56 36.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.942 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.07 -71.85 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.785 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -105.76 -44.84 4.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.731 0.301 . . . . 0.0 111.32 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.98 -25.25 16.4 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.669 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.425 ' N ' ' HA ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.15 -0.928 . . . . 0.0 111.054 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.88 0.371 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.46 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.0 p -87.31 150.1 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.117 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.52 95.6 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.194 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.499 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 8.6 ttp-105 -48.05 -27.36 2.24 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -87.16 0.27 55.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.662 0.268 . . . . 0.0 111.55 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -100.16 146.44 31.95 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.522 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 85.6 Cg_exo -41.41 118.94 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.776 2.317 . . . . 0.0 112.565 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.2 t -39.6 135.27 1.22 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.558 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.31 -21.12 27.83 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.656 2.237 . . . . 0.0 112.557 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.8 p -57.05 -25.57 58.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.35 31.71 45.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.668 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -90.29 -33.83 15.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.86 0.362 . . . . 0.0 110.921 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.53 -25.62 4.47 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.473 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -89.56 147.14 24.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -67.75 168.0 12.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.676 179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -51.9 -64.45 0.81 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.188 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -51.72 -29.02 16.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.873 0.368 . . . . 0.0 111.094 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.0 6.62 41.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.55 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.4 t -150.29 -120.21 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.476 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 41.3 m170 -62.93 -18.76 63.52 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.05 -27.2 6.65 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.803 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.811 0.339 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.476 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 15.0 p -121.39 147.41 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.56 97.35 0.14 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.334 179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.483 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 14.5 ttt180 -47.67 -28.65 2.51 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.58 0.47 54.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.772 0.32 . . . . 0.0 111.637 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.05 145.62 30.73 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.647 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.7 Cg_endo -42.12 119.41 1.24 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.054 2.503 . . . . 0.0 112.429 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.0 t -39.59 134.48 1.26 Allowed Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.559 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.44 -20.43 56.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.615 2.21 . . . . 0.0 112.545 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 32.1 p -57.88 -30.59 65.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.998 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.67 34.01 14.69 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.516 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.2 m -90.2 -44.14 9.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.339 . . . . 0.0 110.933 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 141.06 -37.5 1.64 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.408 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -83.88 145.96 28.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.768 0.318 . . . . 0.0 110.737 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -60.69 171.47 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.571 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.483 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -50.15 -71.95 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.322 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -52.36 -26.07 11.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.919 0.39 . . . . 0.0 111.272 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -92.43 10.65 29.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.76 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.33 -72.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.142 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.7 m170 -116.45 -34.98 4.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.652 0.263 . . . . 0.0 111.468 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.11 -29.61 1.61 Allowed Glycine 0 C--N 1.33 0.228 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.986 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.401 ' HB3' ' NH1' ' A' ' 22' ' ' ARG . 2.4 mtm105 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.889 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.752 0.311 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.49 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.6 p -84.34 148.12 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.72 96.3 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.268 -0.968 . . . . 0.0 111.206 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.528 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 31.7 ttt180 -47.52 -27.7 1.9 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -87.32 0.64 55.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.649 -0.251 . . . . 0.0 111.531 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -102.66 145.44 30.55 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.665 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.4 Cg_endo -40.91 119.8 0.91 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 123.131 2.554 . . . . 0.0 112.625 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.6 t -40.55 134.71 1.58 Allowed Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.505 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.05 -18.38 61.32 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.535 2.156 . . . . 0.0 112.587 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.4 p -57.71 -30.64 65.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.745 0.307 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.79 33.52 11.1 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.551 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.1 m -90.03 -33.97 16.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 127.3 -27.68 4.71 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.438 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 0.2 OUTLIER -91.55 162.96 14.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.768 0.318 . . . . 0.0 110.777 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 3.6 mmtm -74.23 179.79 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -61.79 -65.77 0.64 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.899 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.57 -23.72 42.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.961 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 1.3 tm0? -89.82 2.8 54.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.591 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.22 -70.1 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.659 0.266 . . . . 0.0 110.95 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 22' ' ' ARG . 8.7 m170 -94.08 -86.17 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.451 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.435 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 50.56 -84.05 0.01 OUTLIER Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.081 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 20' ' ' HIS . 17.4 ptm180 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.939 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.1 pttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.77 0.319 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.5 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.5 p -106.96 142.92 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.7 97.59 0.12 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.333 -0.937 . . . . 0.0 111.329 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.468 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 30.7 ttt-85 -47.55 -28.59 2.34 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 20.9 t30 -85.49 0.64 51.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.583 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -100.7 145.43 30.34 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.705 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.0 Cg_exo -40.65 118.96 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.171 2.581 . . . . 0.0 112.48 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.463 ' HG ' ' HG ' ' A' ' 10' ' ' CYS . 23.4 t -43.4 134.44 3.42 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.445 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.43 -17.05 58.31 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.576 2.184 . . . . 0.0 112.788 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.463 ' HG ' ' HG ' ' A' ' 8' ' ' CYS . 20.3 p -56.74 -30.3 63.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.823 0.344 . . . . 0.0 111.122 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.42 32.23 9.7 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.665 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 62.9 p -90.2 -61.46 1.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.889 0.375 . . . . 0.0 110.861 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 153.84 -28.0 0.74 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.549 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mtmm -94.84 141.07 29.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.758 0.313 . . . . 0.0 110.99 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -54.94 164.98 0.71 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.5 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -44.77 -59.82 2.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.825 -179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' HB3' ' NH1' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -55.71 -35.03 65.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.55 -179.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -90.34 12.24 18.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.825 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.78 -70.05 0.18 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.369 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' ARG . 10.3 m170 -99.65 -85.2 0.4 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.487 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.427 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 50.74 -84.13 0.01 OUTLIER Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.879 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.975 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.96 0.41 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 3' ' ' GLY . 12.8 p -106.17 158.81 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.15 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.501 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -71.72 79.49 0.58 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.382 -0.914 . . . . 0.0 111.335 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.493 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -36.38 -30.61 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -178.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -70.38 -0.26 7.88 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.402 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.5 t70 -106.34 145.12 30.35 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.668 0.271 . . . . 0.0 110.579 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.7 Cg_endo -45.29 122.45 4.57 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.808 2.339 . . . . 0.0 112.185 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.6 t -40.27 134.37 1.5 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.417 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.74 -16.79 46.03 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.576 2.184 . . . . 0.0 112.786 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.2 p -57.1 -29.2 63.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.782 0.325 . . . . 0.0 110.963 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.82 31.93 14.11 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.531 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.8 t -90.31 -50.7 5.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.03 -27.94 1.86 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -90.26 159.94 16.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.795 0.331 . . . . 0.0 110.964 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -76.17 163.63 26.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.942 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.493 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -47.32 -64.91 0.66 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.128 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -24.28 36.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.885 0.374 . . . . 0.0 110.823 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -89.9 1.61 56.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.521 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.39 -69.95 0.19 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.684 0.278 . . . . 0.0 111.017 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.51 ' O ' ' N ' ' A' ' 22' ' ' ARG . 7.0 m170 -91.08 -83.99 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.273 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.431 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 49.65 -84.03 0.01 OUTLIER Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.2 -0.524 . . . . 0.0 113.09 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 20' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.894 0.378 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.489 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 13.4 p -125.43 154.17 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.145 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -62.62 94.97 0.11 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.233 178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.464 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 2.1 ttm180 -47.72 -28.17 2.33 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -88.31 0.3 56.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.633 0.254 . . . . 0.0 111.612 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -100.93 146.1 31.55 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.578 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.5 Cg_endo -42.33 119.39 1.31 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.987 2.458 . . . . 0.0 112.25 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.7 t -39.23 134.4 1.14 Allowed Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.599 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.1 -20.93 63.57 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.557 2.171 . . . . 0.0 112.473 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 26.1 p -55.41 -27.9 50.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.034 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.36 31.45 19.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.557 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.4 m -90.21 -41.99 11.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.828 0.347 . . . . 0.0 110.921 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 131.05 -26.47 3.97 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.459 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 0.6 OUTLIER -91.38 131.85 36.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.785 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -51.39 162.61 0.33 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.05 0.452 . . . . 0.0 111.184 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.489 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -44.54 -66.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.945 -179.394 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.95 -22.44 3.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.845 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.436 ' HB3' ' HB3' ' A' ' 14' ' ' LYS . 3.8 mm100 -93.99 2.54 56.06 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.3 t -150.05 -71.74 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.861 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.454 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.4 m170 -88.2 -55.56 3.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.861 0.362 . . . . 0.0 111.254 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.32 -34.19 3.3 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.131 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.791 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.7 mptt . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.861 0.362 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.47 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 14.3 p -88.73 139.43 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.8 99.65 0.14 Allowed Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.303 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.46 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 9.2 ttt180 -48.08 -28.2 2.74 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -85.15 0.24 52.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.692 0.282 . . . . 0.0 111.406 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -102.18 145.57 30.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.505 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.0 Cg_endo -41.58 119.52 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.139 2.559 . . . . 0.0 112.473 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 t -42.32 136.24 2.38 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.384 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.23 -22.47 26.19 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.604 2.203 . . . . 0.0 112.467 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.4 p -59.31 -34.99 72.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.17 38.6 18.14 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.636 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 t -90.29 -36.73 14.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.819 0.343 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.27 -37.28 1.5 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.447 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.65 160.04 18.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.707 0.289 . . . . 0.0 110.703 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -72.15 179.96 3.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.611 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.47 ' CE2' ' CG1' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -55.61 -64.1 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' HA ' ' N ' ' A' ' 22' ' ' ARG . 3.0 pttp -60.08 -16.87 35.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.338 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -89.46 -20.11 24.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.629 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.4 t -123.06 -79.2 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -86.55 -59.22 2.34 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.736 0.303 . . . . 0.0 111.543 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -46.53 -32.09 5.36 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.87 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' N ' ' HA ' ' A' ' 17' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.335 -0.841 . . . . 0.0 111.112 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.797 0.332 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.7 p -97.9 145.16 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.277 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 5' ' ' ASN . . . -69.87 79.26 0.37 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.097 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -33.17 -34.27 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 3' ' ' GLY . 0.4 OUTLIER -56.08 -16.24 4.78 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.581 0.229 . . . . 0.0 111.46 179.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -91.87 144.83 29.92 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.671 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -48.09 117.62 2.64 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.722 2.281 . . . . 0.0 112.167 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 35.8 t -34.09 134.55 0.37 Allowed Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.811 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.62 -16.7 49.93 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.65 2.233 . . . . 0.0 112.808 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.0 p -56.88 -25.04 55.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.712 0.291 . . . . 0.0 111.137 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.94 28.58 31.04 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.693 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -90.36 -46.28 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.872 0.368 . . . . 0.0 110.948 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.06 -26.83 3.08 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.477 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -87.85 144.84 26.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.821 0.343 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.29 158.24 17.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.693 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.6 OUTLIER -46.34 -61.15 1.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.259 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 ptmt -55.34 -22.95 21.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.457 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -98.67 8.98 44.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.797 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.17 -69.15 0.19 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.597 -179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.462 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 7.1 m170 -93.05 -58.14 2.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.777 0.322 . . . . 0.0 111.185 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.82 -26.31 8.03 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.78 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.2 ttt85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.908 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 60.5 mttt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.846 0.355 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 3' ' ' GLY . 12.7 p -121.23 157.82 24.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.239 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.505 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -80.76 85.36 1.37 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.397 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.505 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -37.68 -29.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -69.66 -0.48 6.96 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 3' ' ' GLY . 5.6 t70 -109.01 145.39 31.63 Favored Pre-proline 0 C--N 1.332 -0.182 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -44.3 124.02 4.8 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.851 2.367 . . . . 0.0 112.309 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.414 ' HG ' ' HG ' ' A' ' 10' ' ' CYS . 42.5 t -41.38 136.23 1.83 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.454 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.17 -18.44 44.29 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.569 2.18 . . . . 0.0 112.571 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.414 ' HG ' ' HG ' ' A' ' 8' ' ' CYS . 25.1 p -57.43 -36.33 71.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 110.959 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.2 35.82 6.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.489 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -90.07 -73.94 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 0.0 110.954 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.32 -39.23 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.415 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -79.99 -168.57 1.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 0.0 110.815 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -105.64 173.26 6.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.427 179.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.505 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -54.91 -66.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.319 -179.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.17 -27.52 46.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.192 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.408 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 34.5 mt-30 -95.22 9.42 39.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.542 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.41 -71.25 0.18 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.081 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.487 ' O ' ' N ' ' A' ' 22' ' ' ARG . 11.4 m170 -95.93 -84.05 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.455 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.438 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 50.52 -84.32 0.01 OUTLIER Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.195 -0.526 . . . . 0.0 113.002 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 20' ' ' HIS . 77.5 mtt180 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.889 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.829 0.347 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.6 p -73.13 145.73 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.202 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 5' ' ' ASN . . . -69.54 81.41 0.3 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.365 -0.921 . . . . 0.0 111.316 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.484 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -32.53 -35.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 3' ' ' GLY . 62.7 t30 -56.66 -14.15 3.02 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.31 147.21 32.94 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.825 0.345 . . . . 0.0 110.697 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.66 118.4 3.73 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.473 2.115 . . . . 0.0 112.292 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.474 ' HG ' ' HG ' ' A' ' 10' ' ' CYS . 33.7 t -35.25 134.69 0.46 Allowed Pre-proline 0 N--CA 1.466 0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.594 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.38 -17.75 55.12 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.604 2.203 . . . . 0.0 112.799 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.474 ' HG ' ' HG ' ' A' ' 8' ' ' CYS . 21.9 p -58.53 -27.92 64.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.765 0.317 . . . . 0.0 111.06 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.94 33.05 24.98 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.628 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -90.43 -40.08 12.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 110.837 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.17 -5.13 6.38 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.794 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -112.78 149.14 33.43 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.889 0.376 . . . . 0.0 110.969 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 160.95 17.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.763 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.484 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -51.55 -64.32 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.017 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -23.16 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.404 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -99.28 8.84 44.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.658 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.33 -69.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.755 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -99.07 -54.48 2.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.702 0.287 . . . . 0.0 111.347 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -44.29 -29.19 1.61 Allowed Glycine 0 CA--C 1.518 0.276 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.986 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.889 179.878 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.3 mmmt . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.5 HG22 ' N ' ' A' ' 3' ' ' GLY . 14.4 p -113.55 157.92 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.231 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -78.24 83.57 1.19 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.258 178.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.484 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -37.23 -29.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -72.04 0.37 9.63 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.792 0.294 . . . . 0.0 111.792 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 3' ' ' GLY . 6.2 t70 -107.54 145.16 30.71 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.619 0.247 . . . . 0.0 110.632 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.4 Cg_endo -44.13 122.96 3.93 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.944 2.429 . . . . 0.0 112.309 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.1 t -41.65 135.64 2.04 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.425 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -56.95 -23.81 53.65 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.537 2.158 . . . . 0.0 112.465 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.4 p -59.94 -41.04 90.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.807 0.337 . . . . 0.0 110.816 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.07 39.41 5.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.635 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -90.11 -39.89 12.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.847 0.356 . . . . 0.0 110.934 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.4 -30.59 2.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.396 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.24 140.37 31.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 0.0 110.773 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HG2' ' CG ' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -58.8 169.56 0.97 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.734 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.484 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -48.31 -65.67 0.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.796 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -32.7 33.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.8 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.452 ' CG ' ' HG2' ' A' ' 15' ' ' LYS . 10.8 mm-40 -93.72 13.65 21.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.626 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.69 -70.31 0.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.278 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.487 ' O ' ' N ' ' A' ' 22' ' ' ARG . 10.7 m170 -100.24 -86.86 0.38 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.485 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.439 ' HA2' ' CD2' ' A' ' 16' ' ' TYR . . . 51.58 -84.25 0.01 OUTLIER Glycine 0 C--N 1.333 0.407 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.826 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 20' ' ' HIS . 6.4 mtt-85 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.834 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.821 0.343 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 3' ' ' GLY . 13.3 p -106.14 158.42 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.23 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.507 ' N ' HG22 ' A' ' 2' ' ' VAL . . . -76.73 82.33 1.08 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.273 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -37.42 -29.46 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -70.9 0.15 7.92 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 3' ' ' GLY . 7.2 t70 -108.69 145.61 31.99 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 120.652 0.263 . . . . 0.0 110.515 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.6 Cg_endo -44.47 123.42 4.55 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.853 2.369 . . . . 0.0 112.247 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 t -41.37 135.52 1.89 Allowed Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.481 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.3 -22.24 25.79 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.657 2.238 . . . . 0.0 112.491 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.9 p -58.37 -32.33 68.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.3 36.95 19.4 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.583 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -90.17 -44.61 9.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.811 0.339 . . . . 0.0 110.943 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.72 -27.37 1.63 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.481 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -95.92 152.19 18.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.844 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -71.8 165.99 22.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.486 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.2 OUTLIER -48.23 -67.47 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.224 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -23.02 8.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.43 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.18 8.54 44.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.577 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.37 -70.02 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.76 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -98.55 -52.99 3.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.771 0.319 . . . . 0.0 111.282 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -45.6 -28.2 2.37 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.016 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.211 -0.899 . . . . 0.0 110.903 179.954 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.828 0.347 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.488 ' CG1' ' CE2' ' A' ' 16' ' ' TYR . 12.5 p -116.33 145.87 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.144 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.03 96.03 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.237 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.492 ' HA ' ' HB3' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -47.74 -28.14 2.33 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -90.36 0.72 57.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.659 0.266 . . . . 0.0 111.693 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -96.52 145.65 29.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.692 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 Cg_endo -41.09 117.68 0.58 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.095 2.53 . . . . 0.0 112.53 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 t -40.21 136.15 1.36 Allowed Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.488 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.95 -23.04 32.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.661 2.241 . . . . 0.0 112.64 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.8 p -58.68 -30.82 67.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.957 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.02 35.08 25.24 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.655 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -90.28 -35.81 15.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.799 0.333 . . . . 0.0 110.941 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 133.62 -24.97 3.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.514 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.46 134.61 35.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.783 0.325 . . . . 0.0 111.03 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -61.73 164.62 5.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.776 179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 4' ' ' ARG . 0.1 OUTLIER -45.61 -60.74 2.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.522 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' CG ' ' HG3' ' A' ' 15' ' ' LYS . 7.6 pttt -52.12 -32.03 33.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.476 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.431 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 2.4 mm-40 -89.86 4.95 48.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.46 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.0 t -150.2 -120.57 0.05 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.269 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -51.98 -42.64 63.1 Favored 'General case' 0 C--O 1.231 0.105 0 O-C-N 122.188 -0.32 . . . . 0.0 111.286 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.85 -27.91 59.89 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.598 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.846 0.355 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.462 ' CG1' ' CD2' ' A' ' 16' ' ' TYR . 13.3 p -125.0 150.78 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.191 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.53 80.01 0.43 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.306 -0.949 . . . . 0.0 111.045 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -35.57 -31.01 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -65.96 -5.59 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -101.32 145.46 30.48 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 120.68 0.276 . . . . 0.0 110.643 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -46.75 120.96 4.43 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.823 2.349 . . . . 0.0 112.229 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 t -38.24 134.11 0.92 Allowed Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.591 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.22 -20.69 63.2 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.596 2.197 . . . . 0.0 112.695 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.7 p -58.59 -32.44 68.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.815 0.34 . . . . 0.0 110.939 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.44 35.58 8.57 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.544 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.7 p -90.1 -39.72 12.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.782 0.325 . . . . 0.0 110.915 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.96 -27.62 3.45 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.47 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.45 144.03 26.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.782 0.325 . . . . 0.0 110.879 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -60.26 163.22 5.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.796 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.496 ' CB ' ' HA ' ' A' ' 4' ' ' ARG . 0.3 OUTLIER -46.34 -64.68 0.7 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.307 -179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.414 ' HA ' ' N ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -53.44 -25.99 18.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.268 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -94.37 5.87 50.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.614 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.8 t -150.16 -70.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.741 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.459 ' HB2' ' CD1' ' A' ' 16' ' ' TYR . 11.1 m170 -98.58 -59.87 1.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.725 0.298 . . . . 0.0 111.241 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.95 -27.49 5.02 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.782 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.414 ' N ' ' HA ' ' A' ' 17' ' ' LYS . 17.0 mmt180 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.98 179.928 . . . . . . . . 1 1 . 1 stop_ save_